Provided by MZ Data Products
 
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 

 
FORM 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16
OR 15D-16 OF THE SECURITIES EXCHANGE ACT OF 1934

For the month of August, 2007

(Commission File No. 1-14862 )

 

 
BRASKEM S.A.
(Exact Name as Specified in its Charter)
 
N/A
(Translation of registrant's name into English)
 


Rua Eteno, 1561, Polo Petroquimico de Camacari
Camacari, Bahia - CEP 42810-000 Brazil
(Address of principal executive offices)



Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ___X___       Form 40-F ______

Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(1). _____

Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(7). _____

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes ______       No ___X___

If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- _____.



Braskem EBITDA rises 64%
to R$ 921 million in 2Q07

Net income grows to R$ 281 million in the period

São Paulo, August 8, 2007 --- BRASKEM S.A. (BOVESPA: BRKM3, BRKM5; NYSE: BAK; LATIBEX: XBRK), leader in the thermoplastic resins segment in Latin America and second largest Brazilian industrial company owned by the private sector, announced today its results for the second quarter of 2007 (2Q07).

Upon the acquisition of Grupo Ipiranga’s petrochemical assets by Braskem and Petrobras, in the respective proportions of 60/40, Braskem took over the management of these assets as of April 18, 2007. Accordingly, this release is based on information and comments on the consolidated results. These results include 100% of the results of Ipiranga Química, Ipiranga Petroquímica, Copesul, with the related elimination of minority interests in all these companies, as well as the pro rata consolidation (in accordance with CVM Instruction 247) of the interests in Petroflex Indústria e Comércio S/A and Cetrel S.A. - Empresa de Proteção Ambiental. For more details on the consolidation process, see Exhibit II at the end of this release.

The comparison periods, i.e. 2Q06, 1Q07, 1H06 and 1H07, are presented on a pro forma basis, as if the above mentioned acquisition and its effects on the consolidation had taken place on January 1, 2006. Inputs used in the preparation of pro forma financial information are derived from financial interim statements reviewed by independent external auditors.

On June 30, 2007, the real/dollar exchange rate was R$ 1.9262 /US$ 1.00.

1. MAIN HIGHLIGHTS:

1.1 Gross revenue of R$ 23 billion and net revenue in excess of R$ 18 billion in the last 12 months:

The consolidated net revenue of Braskem in 2Q07 amounted to R$ 5.0 billion, an increase of 23% compared to the same quarter of the previous year. The main drivers of this performance were the growth of 9% in total resin sales volume and the better prices obtained for resins and aromatics (BTX – benzene, toluene, para-xylene and orto-xylene). This revenue includes R$ 444 million from the resale of condensate by Copesul.

Considering the last 12 months (LTM), net revenue reached R$ 18.3 billion, or US$ 8.7 billion.

Excluding revenue from the resale of condensate from Copesul, this amount totals R$ 17.5 billion, or US$ 8.4 billion.

Over the past five years, Braskem net revenue in dollar terms posted average annual growth of 34%.

For further information visit our website at www.braskem.com.br/ir or 
contact the IR team: 
 
Luciana Ferreira    Luiz Henrique Valverde    Silvio Nonaka 
IR Manager    IRO    IR Manager 
Phone: (+55 11) 3443 9178    Phone: (+55 11) 3443 9744    Phone: (+55 11) 3443 9471 
luciana.ferreira@braskem.com.br   luiz.valverde@braskem.com.br    silvio.nonaka@braskem.com.br 



1.2 EBITDA of R$ 3.5 billion in the last 12 months, with 19% EBITDA margin:

Braskem consolidated EBITDA in the second quarter was R$ 921 million, an increase of 64% versus the same period of the previous year. The improved operating performance demonstrated by higher capacity utilization rates, higher sales volume, mainly in the domestic market, and higher profitability of our products were the main drivers of this performance.

This amount was positively impacted by a non-recurring revenue worth R$ 111 million from the reversal of a provision for PIS/Cofins tax. EBITDA margin stood at 18.5% in 2Q07, up from the margin in the same period of last year of 13.9%, and down slightly from the 19.3% in the previous quarter, given the impact of higher raw material costs during 2Q07.

Over the past 12 months, consolidated EBITDA 457 totaled R$ 3.5 billion, equivalent to US$ 1.7 billion, with EBITDA margin of 19.1% . Excluding the effects of condensate resale, EBITDA margin was 20%.

Braskem EBITDA has posted strong growth 2002 since the company's creation in 2002, showing *2Q07 a compound annual growth rate of 33%, considering the EBITDA in the 12 months to 2Q07, and actual EBITDA reported in the previous periods.


1.3 Net Income rises 344% to R$ 408 million:

Braskem consolidated net income was R$ 281 million in 2Q07, reversing the loss of R$ 55 million posted in the same period of last year. The improved operating and financial performance, combined with the positive impact from non-recurring items, such as the reversal of the provision for PIS/COFINS mentioned above, and the recognition of revenue from deferred income tax due to the deductibility of the of goodwill from the merger of Politeno, with an impact of R$ 86 million, were the main drivers related to this improvement.

Braskem’s net income for the 1H07 was R$ 408 million, significantly higher than 2Q06 net income, which was R$ 92 million.

The key macro indicators of Braskem's consolidated performance are shown below:

2


1.4 Braskem produces the first green polyethylene in the world:

On June 21, 2007, Braskem announced the global certification of the first polyethylene from sugarcane ethanol, using technology developed at the Company’s Technology and Innovation Center. The certification was conducted by Beta Analytic, a leading international laboratory, attesting that the product contains 100% renewable raw material. Braskem’s green polymer – a high-density polyethylene, one of the resins most widely used in packaging for the food industry – is the outcome of a research and development project in which the Company has already invested approximately US$ 5 million. A portion of this amount was allocated to the implementation of a pilot unit for the production of ethylene from renewable raw materials, which is already producing enough quantities for commercial development of the product. Target customers of the project, engaged in the automotive, cosmetics and food industries, will soon receive samples of the green polyethylene. Given that this product has the same processing characteristics and application of the polyethylene currently produced by Braskem, plastics converters will not be required to make new investments in their plants to use the green polyethylene.

Braskem expects to start up production and commercialization of polyethylene from ethanol by the end of 2009.

1.5 Odebrecht converts debentures into Braskem shares, and BNDESPAR exchanges Odebrecht debentures for a portion of the converted shares:

On June 19, 2007, Odebrecht took the decision to convert all 59,185 debentures held by it into Braskem shares. The conversion was carried out on July 31, 2007. The debenture balance was R$ 1.2 billion and the conversion amount was R$ 14.37 per share. As a result of this transaction, on July 31, 2007, 77.5 million shares of Braskem were issued, comprising 25.8 million common and 51.7 million class A preferred shares. Also on July 31, BNDES Participações S.A. (BNDESPAR) exchanged the 15,144 Odebrecht debentures held by it for class A preferred shares of Braskem owned by Odebrecht. With these transactions, Braskem's capital share is now represented by 449.4 million shares, comprising 149.8 million common, 298.8 million class A preferred, and 0.8 million class B preferred shares, while the percentage ownership of BNDESPAR and Odebrecht in the total capital of Braskem went from 3.7% to 7.4%, and from 38.1% to 44.4%, respectively. Braskem free float decreased from 49% to 44.9% on July 31, 2007.

Braskem management understands that this decision testifies to the confidence of both Odebrecht and the Brazilian Development Bank (BNDES) in the Brazilian petrochemical sector in general and, in particular, in Braskem’s potential to create value.

As a result of these changes in shareholdings, Braskem's ownership structure on July 31, 2007 had the following composition:

1.6 Public Offer of Shares to Delist Copesul:

On May 21, 2007, CVM (Brazilian Securities Exchange Commission) announced that a public tender offer (“OPA”) for Copesul shares, by reason of transfer of control, was not required, given that the outcome of the transaction would be merely the consolidation of control by Braskem, which already exercised such control, albeit jointly, and primarily on a equal basis with another company, namely Ipiranga Petroquímica S.A.

3


Braskem is continuing the delisting process and awaits CVM approval for the publication of the OPA notice.

1.7 Acquisition of 100% of Ipiranga Petroquímica (IPQ) concluded:

On June 25, 2007, EDSP67 Participações S.A, whose capital is 100% owned by Ipiranga Química, acquired the remaining 7.61% of shares in IPQ’s total capital. The acquisition was effected through a purchase agreement for the shares held by the minority shareholders of IPQ. As a result, Braskem, through Ipiranga Química, now controls 100% of IPQ shares, which allowed the Company to request, and which the CVM has already approved, the delisting of IPQ and the delisting of the company. The shares were purchased for R$ 118 million, an amount already included in the total investment announced for the acquisition of the petrochemical assets of the Ipiranga Group.

2. OPERATING PERFORMANCE:

Braskem’s operating strategy is based on the optimization of assets by maintaining high production capacity utilization rates at all of the industrial units it manages, and prioritizing the sale of higher value-added products in more profitable markets and segments. As a result of this effort, the Company has registered high and growing levels of operating reliability, and reduced volatility in the capacity utilization rates of its plants.

In 2Q07, considering Braskem and Ipiranga Petroquímica units, PP plants operated at 97%, PE plants at 92%, and PVC plants at 88% capacity utilization rates, attributable to a scheduled maintenance stoppage in April. The capacity utilization rate of ethylene at Braskem and Copesul was 96%, with Copesul operating at 99% and the Basic Petrochemicals Unit at 93%.

The evolution of capacity utilization rates for the main products of Braskem consolidated is shown below.


Polyolefins business (Braskem and Ipiranga Petroquímica) recorded in 2Q07 volume 2% higher than in 1Q07, and 4% higher in the comparison of half-year periods, clearly demonstrating the improved reliability and productivity of our plants. Note that the growth of 8% in PP production volume in 1H07 versus a year ago was driven by the increased productivity at Braskem plants, with the capacity utilization rate improving from 92% in 1H06 to 101% in 1H07.

In the Vynils business, a scheduled maintenance stoppage was carried out at the Alagoas PVC plant in 2Q07. In this context, PVC production declined by 2% from 1Q07. Compared to 1H07, production volume posted significant production growth of 10%, due to the improvement at industrial units and the impact from the realization of the 14-day scheduled maintenance stoppage at the Camaçari plant in 2Q06.

In 2Q07, Basic Petrochemicals (Braskem and Copesul) registered stable production versus 1Q07 and higher production in the comparison of half-year periods and also against 2Q06. This improved performance was due to (i) excellent utilization rates at Copesul plants, (ii) better operating reliability of the Basic Petrochemicals unit at Camaçari following the scheduled maintenance mini-stoppage in December 2006, and (ii) higher consumption of ethylene by 2nd generation Braskem units (thermoplastic resin producers) at the Camaçari Petrochemical Complex in Bahia state. Aromatics (BTX) production volume contracted by 12% compared to 1Q07 because of a scheduled stoppage at the Camaçari plant, which impacted the production of para-xylene.

Since the acquisition of Politeno in April 2006 and more recently with the consolidation of the Copesul assets, Braskem operations have become more integrated between the 2nd generation (thermoplastic resins) and 1st generation (basic petrochemicals). In addition to producing 100% of its thermoplastic resins from ethylene and propylene produced internally, Braskem also serves the domestic ethylene and propylene markets, selling 20% of the ethylene it produces in the Southern and Northeastern complexes, and more than half of the propylene it produces in the Northeastern complex. This level of integration has led to more reliable operations and, consequently, more profitable products.

4


 

 Production Volume 
(tons)
   2Q07 
(A)
   1Q07 
(B)
   2Q06 
(C)
  Change
% 
(A)/(B)
  Change
%
(A)/(C)
     1H07
 (D)
  1H06*
 (E)
  Change
%
(D)/(E)
 
Polyolefins                                 
 • PE´s     414,299     409,041    415,968    1     (0)   823,339    803,145    3 
 • PP     178,843     174,351    169,772    3    5    353,194    326,190    8 
 • Total (PE´s + PP)   593,142    583,392    585,740    2    1    1,176,534    1,129,335    4 
 
Vynils                                 
 • PVC     113,911     116,518    100,332    (2)   14    230,429    209,752    10 
 • Soda     114,666     113,757    95,782    1    20    228,423    208,084    10 
 
Basic Petrochemicals                                 
 • Ethylene     601,286     590,071    563,535    2    7    1,191,357    1,137,278    5 
 • Propylene     297,634     296,683    286,830    0    4    594,317    573,234    4 
 • BTX**     221,560     251,602    234,260    (12)    (5)   473,161    458,439    3 
 
*Considers 100% of Politeno at 1Q06 
**BTX - Benzene, Toluene, Ortoxylene and Paraxylene 

3. COMMERCIAL PERFORMANCE:

The demand for thermoplastic resins (PE, PP and PVC) has remained strong since the beginning of the year, supported by economic growth – industrial GDP expanded by 4.8% in 1H07 – and the increase in available income per capita. Within this context, in 1H07 the Brazilian market for thermoplastic resins expanded by 6% compared to the same period of the prior year, led by the PP and PVC markets, which expanded by 8% and 10%, respectively, driven by the construction, automotive and agribusiness sectors, among others. In the same comparison period the PE market expanded by 3%.

In the first half of the year, total sales of thermoplastic resins of Braskem consolidated grew 7% to 1.4 million tons, led by the growth in PVC sales of 10% in the domestic market and 28% in the export market.

Total sales volume (domestic market + exports) of thermoplastic resins of Braskem consolidated was 739 thousand tons in 2Q07, or 9% above the 677 thousand tons sold in 1Q07. This result primarily stems from the 9% increase in domestic volumes to 513 thousand tons in 2Q07, which exceeded the growth in the Brazilian market of 6%. As a result, Braskem consolidated market share increased from 50% in the 1Q07 to 51% in the 2Q07. In the same period exports increased by 10% to 226 thousand tons.

Compared to 2Q06, total sales volume in 2Q07 also increased by 9%, led by growth in PVC sales volumes of 17% in the domestic market and of 31% in the export market.

The following table sets out total sales volume in the domestic and foreign markets.

5


 Total Sales Volume 
(tons)
   2Q07 
(A)
   1Q07 
(B)
   2Q06 
(C)
  Change%
(A)/(B)
  Change%
 (A)/(C)
  1H07
 (D)
  1H06*
(E)
  Change
%

(D)/(E)
 
Polyolefins                                 
 • PE´s     422,932     388,087     405,958    9    4    811,018    777,453    4 
 • PP     194,474     168,995     170,785    15    14    363,469    331,551    10 
 • Total (PE´s + PP)   617,405    557,082    576,743    11    7    1,174,487    1,109,004    6 
 
Vynils                                 
 • PVC     121,150     120,102     103,670    1    17    241,252    215,415    12 
 • Soda     108,999     106,931     100,485    2    8    215,931    205,242    5 
 
Basic Petrochemicals                                 
 • Ethylene     127,005     128,573     110,439       (1)   15    255,577    222,515    15 
 • Propylene     128,816     115,156     109,224    12    18    243,973    228,974    7 
 • BTX**     217,827     219,698     202,702       (1)   7    437,525    391,369    12 
 
*Considers 100% of Politeno at 1Q06 
**BTX - Benzene, Toluene, Ortoxylene and Paraxylene 

In the Polyolefins business (Braskem and Ipiranga Petroquímica), once again sales volume outperformed the market in 2Q07 against 1Q07. This result reflects Braskem commitment to prioritize profitability in the sale of its products without jeopardizing its market share or relationship with customers over the long run. In this context, the Company has undertaken efforts to increase the competitiveness of the petrochemicals and plastics production chain, by launching new products and developing new markets, in addition to building long-term relationships and partnerships with its customers.

Compared to 2Q06, the Brazilian market for PE grew by 4% and Braskem domestic sales remained stable, given that the HDPE market, particularly in this quarter increased by only 1%, impacting our growth in polyethylenes. As a result, PE exports grew by 12% in the same comparison period. Domestic sales of PP rose 2%, while the market expanded by 13%, driven by higher imports – which went from 8% to 11% of the market. Within this scenario, export volumes increased by 21 thousand tons, or 109%.

In the Vynils business, domestic PVC sales in 2Q07 grew by 7% when compared to 1Q07, with a market share gain of 3 percentage points growing to 56% in the quarter. The market contracted by 4%, chiefly on account of the reduction of inventories by distributors. Imports also declined, from 23% to 17% of the market in the same comparison period.

Compared to 2Q06, Braskem domestic sales expanded by 16%, while the market grew by 9%, once again driven by the improved performance of the construction and related sectors, as well as operating problems faced by our main competitor.

For the Basic Petrochemicals unit, ethylene volumes sold in 2Q07 remained unchanged from the prior quarter and increased by 15% compared to 2Q06, due to the higher consumption by its customers, given the higher operating stability at industrial units. Propylene sales volume, in turn, grew by 12% from 1Q07 and by 18% compared to 2Q06, owing to higher production levels in the 2Q07.

The volume of aromatics sales was in line with 1Q07, led by export performance. Benzene sales volume accounted for the bulk of aromatics sales. Note that benzene prices have risen by 43% since the end of 2005, and by 12% between 2Q07 and 1Q07, and its price is expected to remain above historical levels due to the global supply-demand balance.

4. ECONOMIC-FINANCIAL PERFORMANCE:

4.1 Net Revenue

In 2Q07, Braskem consolidated net revenue totaled R$ 5.0 billion, up 23% from the pro forma results of 2Q06. The main drivers of this performance were the 9% growth in resin sales volume combined with the better prices for resin and for aromatics. These drivers were partly offset by the average appreciation in the Brazilian real between the periods of 9%, since prices use as a benchmark the international market, where prices are quoted in US$/t.

6


The net revenue of R$ 5.0 billion includes R$ 444 million from the resale of condensate between Copesul and the refineries in the South. The transaction involves the processing of condensate by the refineries and seeks to improve the productivity and competitiveness of Copesul through reduction in raw material costs.


Compared to 1Q07, net revenue was 12% higher, driven by a 9% increase in the sale of thermoplastic resins, ethylene, propylene and aromatics as well as the increase in international prices for PE, PP and PVC. These factors were partially offset by a 6% average appreciation of the Real.


Consolidated net revenue amounted to R$ 9.4 billion in 1H07, up 17% over 1H06. The main drivers of this expansion were the increases of 7% in resin sales volume and 12% in aromatics sales volume, as well as the better prices of resins, ethylene, propylene and aromatics in the international markets and their respective impacts on the domestic market.

A breakdown of net revenue in 2Q07 is shown below:

7


4.1.1 Exports

Braskem has invested in strengthening its presence in the international market. To this end, since 2006 the Company has built direct relationships with some of its customers, through distribution operations in Europe, the United States and Argentina, markets considered strategic by the Company. These investments have resulted in better prices for its resins, particularly PE and PP.

In this context, consolidated exports in 2Q07 reached US$ 675 million, or 27% of net revenue, up 33% from the US$ 506 million in 1Q07, which corresponded to 24% of net revenue. The higher volume channeled to export markets in 2Q07 compared to 1Q07 and the recovery of international prices are the factors behind the increase. The growth in revenue from exports in 2Q07 increased by 36% versus 2Q06. Over the last 12 months export revenue totaled US$ 2.4 billion.


8



Given effect to the distribution operations outside of Brazil, Braskem has maintained a high percentage of its exports to South America and increase export volume to Europe, through direct access to the final client.

4.2. Cost of Goods Sold (CoGS)

In the second quarter of 2007, cost of goods sold (CoGS) of Braskem consolidated was R$ 4.0 billion, an 18% increase from CoGS in both 1Q07 and 2Q06. The increase in sales volume and the cost of raw materials impacted CoGS and were partly offset by the improved productivity at our plants, as well as the average appreciation in the Brazilian real of 6% compared to 1Q07 and of 9% when compared to 2Q06.

In 1H07, CoGS was R$ 7.5 billion, representing an 11% increase when compared to the R$ 6.7 billion in 1H06. The 9% increase in total sales volume and naphtha costs R$ 125 million higher were responsible for this variation.


The average price of naphtha ARA (Amsterdam – Rotterdam – Antwerp) increased significantly during 2Q07 to an average of US$ 670/ton, equal in dollars to a 21% increase from 1Q07. This growth, coupled with the higher volume consumed, led to a naphtha cost R$ 389 million (or 17%) higher in 2Q07 than in 1Q07.

In addition to naphtha, Company costs have been impacted over the past 2 years by the scarcity and irregularity in the supply of natural gas to Camaçari. It is expected that this situation will be solved as from 4Q07, when gas from the Manati Field begins to reach Camaçari. In the 1H07 alone, higher energy costs driven by the use of fuel oil replacing natural gas negatively impacted Braskem results by R$ 24 million.

During 2Q07, Braskem purchased 2,034 thousand tons of naphtha, of which 1,259 thousand tons (62%) were acquired from Petrobras - its main raw material supplier. The remaining 775 thousand tons (38%) were directly imported by the Company, primarily from North Africa and Argentina.

Depreciation and amortization expenses included in CoGS amounted to R$ 202 million in 2Q07, slightly above the figure in the previous quarter, on account of the higher volumes sold in 2Q07.

4.3. Selling, General and Administrative Expenses (SG&A)

Braskem is focused on maintaining its fixed costs and expenses within parameters that ensure its global competitiveness. In this context, the Company launched at the start of the quarter a program to reduce fixed costs and expenses, supported by an international consulting firm. The process mapping phase has been concluded and reduction opportunities have already been identified. The implementation of the program will begin already in August and the results of this program will be fully captured in 2008.

9


In 2Q07, consolidated general and administrative expenses amounted to R$ 333 million, a reduction of R$ 11 million versus 1Q07.

Breaking this figure down, consolidated general and administrative expenses were R$ 205 million, up from R$ 176 million in 1Q07, due to: (i) non-recurring revenue in 1Q07 of R$ 17 million, relating to an adjustment to the provision for a future disbursement by Braskem in the event of the liquidation of the Petros plan, which involves Braskem employees formerly employed by Copene, and (ii) a non-recurring expense in 2Q07 in the amount of R$ 10 million, related to the of Copesul, Ipiranga Química and Ipiranga Petroquímica.

Compared to 2Q06, general and administrative expenses increased by R$ 31 million, chiefly due to: (i) higher personnel expenses from the annual wage increase in 4Q06 under the collective bargaining agreement; (ii) higher expenses with auditing; and (iii) a non-recurring expense related to the beginning of the integration process, as described above.

The selling expenses of Braskem consolidated in 2Q07 were R$ 128 million, down R$ 40 million from 1Q07, mainly driven by a reduction in the provision for doubtful accounts of R$ 35 million, of which R$ 13 million derived from the recovery of credits in this quarter, compared to an expense of R$ 22 million in the previous quarter.

Compared to 2Q06, selling expenses grew by R$ 16 million, mostly on account of the higher export volumes in 2Q07.

4.4. EBITDA

Braskem consolidated EBITDA in 2Q07 was R$ 921 million, 64% higher than in the same period of last year, the main drivers of which were higher capacity utilization rates, improved sales volumes and better profitability in the commercialization of our products. EBITDA in 2Q07 was also positively impacted by non-recurring operating revenue in the amount of R$ 111 million from the reversal of a provision for a PIS/COFINS tax, whose claim had final judgment.

Braskem EBITDA margin in 2Q07 was 18.5% in the quarter, up from 13.9% in the same period a year ago and down slightly from the margin of 19.3% in 1Q07.

In dollar terms, EBITDA in 2Q07 was US$ 465 million, or US$ 409 million excluding the effect from the non-recurring revenue.

Against 1Q07, Braskem EBITDA rose by 8%, impacted by the factors cited above, while in the comparison of half-year periods, EBITDA posted significant growth of 37%, rising from R$ 1.3 billion in 1H06 to R$ 1.8 billion in 1H07.

10


4.5. Investments in Subsidiaries and Affiliated Companies

Braskem’s consolidated equity in the earnings of subsidiary and affiliated companies in 2Q07 was an expense of R$ 22 million. This amount primarily refers to goodwill amortization on investments in Ipiranga Química, Copesul and Petroflex. The portion relating to investment in the petrochemical assets of the Ipiranga Group equals R$ 14 million.

Compared to 1Q07, when this expense amounted to R$ 35 million, the R$ 13 million positive variation refers mainly to the merger of Politeno in April 2007 and its related goodwill. Since then the amortization of this goodwill has ceased to impact this line and is impacting the line of depreciation and amortization expenses.

(R$ 000)                    
 
Equity Income    2Q07    1Q07    2Q06    1H07    1H06* 
 
Equity Income    915    (747)   671    168    (293)
  Rionil      (82)     (76)   20 
  Others    908    (665)   667    244    (313)
FX Variation    (3,893)   (2,808)   (366)   (6,701)   (218)
 Others    3,398    5,135    17,314    8,533     56,292 
Sub Total (before amortization)   420    1,580    17,619    2,000     55,781 
Amortization Goodwill    (22,118)   (36,739)   11,032    (58,857)   (41,955)
                     
           
TOTAL    (21,698)   (35,159)   28,651    (56,857)   13,826 
           
* Considers 100% of Politeno at 1Q06

4.6. Net Financial Result

Net financial result for Braskem consolidated in 2Q07 was an expense of R$ 59 million, compared to an expense of R$ 104 million in 1Q07, or a 43% reduction. The 6% appreciation in the Brazilian real against the dollar in the quarter positively impacted financial result by R$ 271 million while the 4% appreciation in 1Q07, had a positive impact on financial result of R$ 190 million.

Excluding the effects of foreign exchange and monetary variations, net financial result was an expense of R$ 270 million, up 5% from the R$ 257 million in 1Q07, and a 23% increase compared with the R$ 220 million in the same period of the prior year.

The main negative drivers affecting 2Q07 compared to the prior period were: (i) the increase of R$ 16 million in "other financial expenses" arising from derivative transactions (hedge), discounts granted to clients for early payment, and higher charges from raw material suppliers, and (ii) the increase in CPMF/IOF/IR taxes and bank fees in the amount of R$ 7 million, as a result of the higher volume of financial transactions in 2Q07 (funding, amortization, acquisitions and raw materials). These impacts were partly offset by an increase of R$ 11 million in financial income from investments (interest).

Compared to 2Q06, excluding the effects of foreign exchange and monetary variations, the increase amounted to R$ 50 million, mainly comprising: (i) reduced interest on financial income in the amount of R$ 33 million, chiefly due to the decline in market interest rates, and (ii) the R$ 36 million increase in Other financial expenses, arising from derivative (hedge) contract expenses, discounts granted to clients for early payment, and supplier charges. These negative effects were partly offset by the decline in interest and expenses on vendor transactions totaling R$ 13 million, due to the reduction in gross debt.

11


The table below shows the composition of Braskem consolidated financial results on a quarterly basis.

(R$ million)                    
    2Q07    1Q07    2Q06    1H07    1H06* 
Financial Expenses    37    (77)   (369)   (40)   (318)
                   Interest / Vendor    (162)   (160)   (175)   (322)   (351)
                   Monetary Variation    (62)   (64)   (62)   (126)   (121)
                   Foreign Exchange Variation    394    259    (28)   653     384 
                   CPMF/IOF/Income Tax/Banking Expenses    (39)   (32)   (44)   (71)   (73)
                   Interest on Fiscal Provisions    (26)   (28)   (28)   (53)   (72)
                   Other    (69)   (53)   (33)   (122)   (86)
Financial Revenue    (96)   (27)   52    (122)   (39)
                   Interest    26    15    59    40     104 
                   Monetary Variation    3    28    5    30    18 
                   Foreign Exchange Variation    (124)   (69)   (12)   (193)   (160)
         
Net Financial Result    (59)   (104)   (317)   (162)   (357)
 


(R$ million)                    
    2Q07    1Q07    2Q06    1H07    1H06* 
 
 
Financial Result excluding F/X and MV    (270)   (257)   (220)   (528)   (478)
 
 
Foreign Exchange and Monetary Variations:                     
Foreign Exchange Variation (F/X)   271    190    (40)   460     224 
Monetary Variation (MV)   (59)   (36)   (56)   (95)   (103)
 
 
 
Net Financial Result    (59)   (104)   (317)   (162)   (357)
 
* Considers 100% of Politeno at 1Q06 
 

4.7. Net Income

Braskem net income excluding minority interests in 2Q07 totaled R$ 281 million, a reversal from the loss of R$ 55 million posted in 2Q06, mainly due to the better operating performance in 2Q07.

Net income in 2Q07 was R$ 154 million higher than the R$ 127 million posted in 1Q07. The main drivers of this increase was stronger EBITDA, improved financial results, and recognition of an income tax credit of R$ 86 million relating to the deductibility of the goodwill from the merger of Politeno.

In 1H07, Braskem recorded net income of R$ 408 million, up R$ 316 million on the R$ 92 million in 1H06, mainly driven by the Company’s better operating and financial performance in 2007.

4.8. Free Cash Flow

Operating cash generation was R$ 754 million in 2Q07, compared to R$ 1.1 billion in the previous quarter. This variation is mainly attributable to a R$ 367 million increase in 1Q07 relating to the transfer to cash and cash equivalents of funds previously invested with instruments without immediate liquidity (over 90 days), and to the lengthening of terms with suppliers.

Compared to 2Q06, operating cash generation increased by R$ 324 million, mostly driven by the better operating performance in the period.

In respect to free cash flow, the higher investment in 2Q07 was due to the acquisition of the petrochemical assets of the Ipiranga Group and the purchase of the minority interests of Ipiranga Petroquímica in April and June, respectively.

12


R$ million    2Q07    1Q07    2Q06    1H07    1H06* 
 
Operating Cash Flow    754    1,112    430    1,866    817 
 
Interest paid    (176)   (163)   (188)   (338)   (325)
Investment Activities    (1,114)   (224)   (494)   (1,338)   (696)
Share Buy-back        (57)     (57)
Taxes paid    (85)   (114)   (78)   (199)   (121)
 
Free Cash Flow (FCF)   (620)   611    (387)   (9)   (382)

 
*Includes 100% of Politeno at 1Q06

 

4.9 – Capital Structure and Liquidity

On June 30, 2007, Braskem’s gross debt was 18% lower than on March 31, 2007. The decline is mainly attributable to the conversion into Braskem shares of debentures issued by the Company and held by Odebrecht, resulting in an R$ 1.2 billion reduction in the Company's gross debt. Also, the debt was reduced due to the early payment of one of the debentures issues by Braskem in the amount of R$ 150 million, as well as the effect of the appreciation in the Brazilian real on the portion of debt denominated in foreign currency, of approximately R$ 270 million. In turn, consolidated cash and cash equivalents remained stable at R$ 2.1 billion.

As such, Braskem’s consolidated net debt stood at R$ 5.2 billion on June 30, declining by R$ 1.6 billion from the R$ 6.9 billion on March 31, 2007. In dollar terms, the decline was of approximately US$ 600 million, given the 6% appreciation in the real in the period, leading Braskem’s consolidated net debt to stand at US$ 2.7 billion on June 30, 2007.

The Company's financial leverage measured by the ratio of Net Debt to EBITDA was 2.18 times (x) at end 1Q07 (last 12 months), declining by 32% to 1.49x at end 2Q07 (last 12 months). Over the course of the acquisition of the petrochemical assets of Grupo Ipiranga and the delisting of Copesul, the Company's indebtedness is expected to return to a level of Net Debt/EBITDA between 2.0x and 2.3x.


13


The average debt maturity is 13 years, allowing the Company to ensure an adequate annual maturity schedule, in addition to higher efficiency in the allocation of funds to operating working capital. By the end of June 2007, the dollar-linked debt had a relative increase, since the debt denominated in real was reduced by the conversion of the debentures held by Odebrecht. Accordingly, this percentage, which stood at 52% on March 31, 2007, rose to 64% as of June 30, 2007.


The following chart depicts the consolidated amortization schedule of the Company on June 30, 2007.

5. CAPITAL EXPENDITURES:

In line with its commitment to capital discipline and making investments with returns above its capital cost, in 1H07 Braskem consolidated capital expenditure totaled R$ 372 million (not including capitalized interest of R$ 26 million), compared to R$ 337 million in 1H06. These funds were used in operating, health, safety and environmental areas, and in information technology (2nd phase of the Fórmula Braskem project – R$ 32 million), benefiting all of the Company's business units.

Investments in Braskem (parent company) accounted for 84% of total investments in the period.

14



Additionally, the Company made expenditures of R$ 88 million for scheduled maintenance stoppages, consistent with its goal of maintaining all of its plants operating at high reliability levels.

6. CAPITAL MARKETS AND INVESTOR RELATIONS

Braskem class "A" preferred shares traded on the São Paulo Stock Exchange (BOVESPA) (“BRKM5”) closed the quarter quoted at R$ 17.26 per share, up 13.5% in the period, versus a gain in the Ibovespa index of 18.7% .

Braskem ADRs (BAK) listed on the NYSE traded at US$ 18.04 per ADR at the end of the quarter, gaining 22.8% in the period, versus a gain of 8.5% in the Dow Jones Industrial Index.

XBRK shares traded on the Latibex closed the quarter at € 6.69 per XBRK, for a gain of 17.2% in the period, while the FTSE100 Europe remained virtually unchanged, rising by 0.2% .

The average daily financial volume of Braskem class "A" preferred shares on the Bovespa (BRKM5) in the 2Q07 increased by 7.5%, from R$ 26.2 million in 1Q07 to R$ 28.1 million in 2Q07. On the NYSE, the average daily trading volume of Braskem ADRs (BAK) increased by 31.9%, from US$ 3.3 million in 1Q07 to US$ 4.3 million in 2Q07. On the Latibex, average trading volume of XBRK declined by 13.9% to € 69,400 in 2Q07 from € 80,500 in 1Q07.

On August 2, 2007, the Bovespa disclosed the preliminary theoretical portfolio for the Ibovespa index valid from September to December 2007. Braskem ranked 22nd in liquidity on the Bovespa, with a weighting of 1.42% in the index.

Stock Performance - BRKM5    06/30/07    03/31/07    12/31/06    09/30/06    06/30/06 
Closing Price (R$ per share)   17.26    15.21    14.85    13.39    13.15 
Return in the Quarter (%)   13      11      (17)
Accumulated Return (%)*    578    498    483    426    417 
Bovespa Index Accumulated Return (%)*    383    306    295    223    225 
Average Daily Trading Volume (R$ thousand)   28,135    26,178    23,306    21,513    24,256 
Market Capitalization (R$ million) **    6,420    5,657    5,521    4,980    4,892 
ADR Performance - BAK (1 ADR = 2 BRKM5)   06/30/07    03/31/07    12/31/06    09/30/06    06/30/06 
Closing Price (US$ per ADR)   18.04    14.69    14.59    12.59    12.19 
Return in the Quarter (%)   23      16      (18)
Accumulated Return (%)*    993    790    784    663    639 
Average Daily Trading Volume (US$ thousand)   4,305    3,264    2,165    2,212    3,032 
Market Capitalization (US$ million)   3,333    2,759    2,583    2,291    2,260 
XBRK Performance on Latibex    06/30/07    03/31/07    12/31/06    09/30/06    06/30/06 
Closing Price (Euros per Share)   6.69    5.71    5.33    4.95    4.79 
Return in the Quarter (%)   17          (23)
Accumulated Return (%)*    968    826    771    716    693 
Average Daily Trading Volume (Thousand Euros)   69    81    62    51    66 
Share Distribution    06/30/07    03/31/07    12/31/06    09/30/06    06/30/06 
Total Number of Shares (thousand)   371,936    370,402    370,402    370,402    370,402 
   >    >    >    >    >  
. Common Shares (ON) - BRKM3    123,979    123,492    123,492    123,492    123,492 
   >    >    >    >    >  
. Preferred Shares Class "A" (PNA) - BRKM5    247,154    246,107    246,107    246,107    246,107 
   >    >    >    >    >  
. Preferred Shares Class "B" (PNB) - BRKM6    803    803    803    803    803 
   >    >    >      >  
 (-) Shares in Treasury (PNA) (1) - BRKM5    (16,594)   (14,363)   (14,363)   (11,163)   (4,471)
     >    >    >    >  
= Total Number of Shares (ex Treasury)   355,342    356,039    356,039    359,239    365,931 
 
* Accumulated return since the market closing on December 31, 2002. 
** Do not considers the conversion of the debentures. After the conversion, market cap woud be R$ 7.8 billion. 
Source: Economática/Braskem 
(1) The increase of shares in Treasury at 2Q07 derives from the merger of Politeno on April, 2007, wich had 2.2 million Braskem shares 

 

15


7. OUTLOOK:

With respect to the factors affecting its operating results, Braskem's expectations point to the maintenance of robust global economic performance over the next few years, with the major economies continuing to expand. This scenario favors the petrochemical industry in the light of the existing elasticity between the demand for petrochemical products and economic growth rates. Capacity utilization rates are expected to remain at high levels in the coming years, as a result of the projected balance between the demand for thermoplastic resins in the international market and the supply of these products, in particular after delays in the start-up of new production capacities in Iran were confirmed (Olefins 9 and 10), as well as operatingproblems at some of these plants. This scenario points to the maintenance of thermoplastic resin prices at high levels in the international markets, with potential positive impacts on Braskem’s profitability, in both the domestic and foreign markets. The spread between the PE price and naphtha price in June was above the average of 1H06 and even 1H07, suggesting a recovery in prices following the recent hikes in oil and naphtha prices. This recent increase in spreads may be impacted by new increases in oil and naphtha prices.

On the domestic front, in the short-term Braskem is working with a scenario of sustained economic growth, with inflation under control and the potential for additional cuts in interest rates, stimulating economic growth and consumption, as already seen in 1H07, in particular from March on. The expected improvement in available income levels, the increased offering of credit and stronger construction activity, among other factors, point to expansion in the Brazilian thermoplastic resin market of around 10% per year. Braskem expects to take advantage of this environment, drawing on its leadership position in the market and unique structure of products and services, based on innovation and technology.

In the short term, the Company has invested mostly in projects allocated to operating areas (productivity improvement, technological upgrades and modernization, and equipment replacement) and investments in health, safety and the environment and in the 2nd phase of the Fórmula Braskem program. In this context, Braskem consolidated expects to invest approximately R$ 800 million in 2007, excluding the estimated amount for scheduled maintenance stoppages of R$ 200 million.

From a strategic viewpoint, Braskem steadily pursues its growth strategy with the creation of value for all its stockholders. To this end, in the short term the Company focuses on two fronts: consolidation of the Brazilian petrochemical industry and access to competitive raw materials, a factor of increasing importance for ensuring competitiveness in a global environment.

Accordingly, the Petroquímica Paulínia project is on track and the plant, with initial capacity of 300 thousand tons of PP (that can be potentially raised to 350 thousand tons), is expected to start operations in 2Q08. Petroquímica Paulínia is a joint venture with Petrobras, in the proportion of 60% for Braskem and 40% for Petrobras. The total investment in the project is R$ 704 million under a project finance type arrangement, with a debt/equity structure of 65/35, and most of the financing provided by the BNDES. In 2007, Braskem expects to contribute approximately R$ 80 million.

Furthermore, Braskem should expand its production capacity by implementing new projects – while always maintaining capital discipline – through investments that provide returns above the Company's cost of capital. These new projects include additional capacity expansions in existing plants, as well as a new PP plant (300 thousand tons) at the Camaçari Petrochemical Complex, starting in 2010. These projects are subject to approval by the Board of Directors.

Among the growth projects involving improved competitiveness by obtaining competitive raw materials, Braskem is working on the project for a PP plant with capacity of 450 thousand tons with estimated investment of US$ 370 million at the Jose Complex in Venezuela, in partnership at equal terms with Pequiven. The plant is scheduled to start activities by the end of the first half 2010, using propylene supplied by Pequiven.

An additional project involves an ethylene cracker for the production of 1.3 million tons of ethylene, 1.1 million tons of PE, as well as other 2nd generation products, for estimated investment of US$ 2.5 billion, also at the Jose Complex in Venezuela, and also under a 50-50 partnership with Pequiven. These plants are scheduled to start operations by late of the first half 2012, using ethane from natural gas to be supplied by PDVSA.

The Company expects both projects to be financed under project finance arrangements, with the participation of multilateral credit agencies, export credit agencies, private and development banks, thus minimizing the use of the company's own resources. The projects will meet the resin requirements of the Venezuelan market and provide a competitive platform for the export of these products to North America, Europe and the west coast of South America.

Concerning the petrochemical sector consolidation in Brazil, Braskem anticipates good opportunities to capture synergies and create value from the integration of the Ipiranga Química, Ipiranga Petroquímica, Copesul and Braskem operations at the Triunfo Petrochemical Complex in Rio Grande do Sul state. Braskem has implemented a new corporate governance model at Copesul and Ipiranga Química, Ipiranga Petroquímica, in line with the respective stakes with Braskem as controlling shareholder and Petrobras as relevant minority shareholder. Braskem teams are already working on the integration process to identify synergy opportunities at the three companies.

16


All these growth fronts are intended to position Braskem among the 10 largest global petrochemical companies by market capitalization, generating value for all shareholders.

8. ANALYSIS OF BRASKEM RESULTS:

The following analysis covers only Braskem before consolidation of the Ipiranga Group petrochemical assets and the pro rata consolidation (CVM 247) of other investees.

8.1 Operating Performance

Since the beginning of the year, the Company has shown high operating reliability levels, operating its plants with lower volatility in capacity utilization rates. In 2Q07, the utilization rate for ethylene was 93%, in line with 1Q07, while PE and PP increased by 2 p.p. compared to 1Q07, to 94% and 102%, respectively. The utilization rate for PVC was 88% on account of a scheduled maintenance stoppage at the Alagoas plant, originally scheduled for March but carried out in April.

The Polyolefins unit production volume was 3% higher compared to both 1Q07 and 2Q06, evidencing the improved productivity of our plants. In the comparison of half-year periods, this performance was even more significant, with production volume growing by 6%.

At the Vynils unit a scheduled maintenance stoppage at the Alagoas PVC plant was carried out in 2Q07. Within this context, total PVC production fell 2% from 1Q07. In the 1H07, production volume increased by 10% versus the same period a year ago, due to better productivity at the industrial units and the impact from the 14-day scheduled stoppage at the Camaçari plant in 2Q06.

In 2Q07, production from the Basic Petrochemicals unit, considering only ethylene and propylene, remained stable compared to 1Q07 and increased by 8% from 2Q06. This increase was due to (i) the improved operating reliability of the units following the scheduled mini-stoppage for maintenance in December 2006, and (ii) higher consumption of ethylene by 2nd generation Braskem units (thermoplastic resin producers) at the Camaçari Petrochemical Complex. Aromatics (BTX) production volume fell 14% quarter-on-quarter because the scheduled stoppage at the Camaçari plant impacted the production of para-xylene.

17


Production Volume 
(ton)
   2Q07
 (A)
   1Q07
 (B)
   2Q06 
(C)
  Change
 %
 (A)/(B)
  Change
 % 
(A)/(C)
   1H07
 (D)
  1H06* 
(E)
  Change 
% 
(D)/(E)
               
               
               
               
 
Polyolefins Unit                                 
 . PE´s - Polyethylene     295,382     286,116    290,983    3    2     581,497    559,693    4 
 . PP - Polypropylene     142,412     137,415    135,155    4    5     279,827    256,591    9 
 . Total (PE´s + PP)   437,794    423,531    426,138    3    3    861,325    816,284    6 
 
Vinyls Unit                                 
 . PVC - Polyvinyl Chloride     113,911     116,518    100,332    (2)   14     230,429    209,752    10 
 . Caustic Soda     114,666     113,757    95,782    1    20     228,423    208,084    10 
 
Basic Petrochemical Unit                                 
 . Ethylene     298,368     293,760    275,103    2    8     592,128    558,739    6 
 . Propylene     142,616     141,205    133,054    1    7     283,821    268,422    6 
 . BTX**     144,216     168,638    168,221    (14)   (14)    312,854    315,938    (1)

 
*Includes 100% of Politeno at 1Q06 
**BTX - Benzene, Toluene, Ortho-xylene and Para-xylene 

Based on the core competitiveness criteria of the world petrochemical industry – global scale, updated technology and competitive costs, Braskem decided to temporarily suspend the production of PET resin and discontinue its DMT production unit in Bahia, with the objective of maximizing the profitability of its operations and maximizing returns for shareholders. Braskem will analyze the potential resumption of PET production using a new technological route that ensures competitive costs for the polyester chain in Brazil. The supply of PET resin to all customers is guaranteed through an agreement entered into with M&G Polímeros Brasil S.A., one of the leading producers of this resin in Brazil and worldwide. Braskem maintains its current commercial policy for this product, including technical assistance, so as to ensure excellent services to all its customers. The deactivation of this unit will have a non-recurring impact on Braskem's result in the amount of R$ 25 million, in the non-operating expenses line.

8.2 Commercial Performance

Total sales volume (domestic market + exports) of Braskem thermoplastic resins (PE, PP and PVC) amounted to 590 thousand tons in 2Q07, increasing by 13% compared to the 524 thousand tons sold in 1Q07. The positive result is mainly attributable to a 14% increase in domestic volumes, which exceeded the growth in the Brazilian market of 6%. In the same period exports grew by 10% to 167 thousand tons.

Compared to 2Q06, total resin sales volume rose 13%, with domestic sales rising 7% and exports growing by 30%, or 38 thousand tons.

The following table shows total volumes sold in the domestic and export markets.

Total Sales Volume 
(ton)
   2Q07 
(A)
   1Q07
 (B)
   2Q06
 (C)
  Change 
%
 (A)/(B)
  Change
 % 
(A)/(C)
   1H07
 (D)
  1H06* 
(E)
  Change
 %
 (D)/(E)
               
               
               
               
 
Polyolefins Unit                                 
 • PE´s - Polyethylene    313,345    268,389    285,047    17    10     581,734    541,711    7 
 • PP - Polypropylene    155,303    135,201    135,344    15    15     290,504    256,963    13 
 • Total (PE´s + PP)   468,648    403,590    420,392    16    11    872,238    798,675    9 
 
Vinyls Unit                                 
 • PVC - Polyvinyl Chloride    121,150    120,102    103,670    1    17     241,252    215,415    12 
 • Caustic Soda    109,349    107,419    101,189    2    8     216,767    206,540    5 
 
Basic Petrochemical Unit                                 
 • Ethylene    60,724    62,051    58,382    (2)   4     122,775    116,867    5 
 • Propylene    126,248    111,257    106,186    13    19     237,506    222,220    7 
 • BTX**    139,655    135,802    131,442    3    6     275,457    250,109    10 

 
*Includes 100% of Politeno at 1Q06 
**BTX - Benzene, Toluene, Ortho-xylene and Para-xylene 

At the Polyolefins Unit, once again PE and PP sales volumes outperformed the market in 2Q07 against 1Q07. Note that Braskem emphasizes the profitable sale of its products without jeopardizing its market share or relationship with customers over the long run. Within this context, the balance of profitability and market share gave rise to an increase in Braskem's share in the Brazilian market for PE and PP in 2Q07, once again confirming its leadership position in this segment.

18


 

Domestic PE sales grew 17% over 1Q07, above the 6% increase of the Brazilian market in general. PE exports increased by 17% in the same comparison period, as a result of better prices in this market.

In relation to 2Q06, the Brazilian PE market grew 4%, while Braskem domestic sales were 2% higher, since the HDPE market, which represents a great portion of the PE sold by Braskem, particularly in this quarter, grew only 1%. Exports grew 23% in the same comparison period.

Braskem has made efforts to increase the competitiveness of the petrochemicals and plastics production chain, by launching new products and developing new markets and building long-term relationships and partnerships with its customers. As a result of these efforts, PP sales in the domestic market rose 15% compared to 1Q07, versus Brazilian domestic demand growth of 14%.

Compared to 2Q06, domestic PP sales increased by 7%, versus market growth of 12%, driven by higher imports, which went from 8% of 11% of the market. In this scenario, the volume of Braskem exports increased by 11 thousand tons, or 72%.

At the Vynils Unit, domestic sales of PVC grew by 7% when comparing 2Q07 with 1Q07, with a 3 percentage points gain in market share, which stood at 56% in 2Q07. The market contracted by 4%, mostly due to reduction in inventories at certain customers. Imports went from 23% to 17% of the market in the same comparison period, also contributing to the decline.

Domestic sales grew by 16% compared to 2Q06, while the market grew by 9%, once more driven by the better performance of construction-related segments, as well as the operating problems faced by our main competitor.

At the Basic Petrochemicals Unit, ethylene volumes sold in 2Q07 were 2% down from the prior quarter and 4% up compared to 2Q06, on account of higher consumption by its customers, driven by enhanced operating stability. The volume of propylene sales, in turn, increased by 13% and 19% compared to 1Q07 and 2Q06, respectively, owing to the expanded production in 2Q07.

Aromatics sales volume increased by 3% from 1Q07, driven by exports. Sales of benzene accounted for 66% of total sales of aromatics. Note that benzene prices have risen 43% since the end of 2005, and by 12% between 2Q07 and 1Q07, and prices of this product are expected to remain above historical amounts, given the supply-demand balance.

8.3 Net Revenue

Net revenue amounted to R$ 3.1 billion in 2Q07, up 11% versus 2Q06. The increase is mainly associated with the 13% growth in the sales volume of resins and the improved prices for resins and for aromatics. These factors were partly countered by the average appreciation in the Brazilian real of 9%.

In the comparison of half-year periods, net revenue in 1H07 totaled R$ 6.0 billion, up 8% on 1H06. The main drivers of this increase were the increases of 10% in the resins volumes and 10% in aromatics volumes, and the better prices for resins, ethylene, propylene and aromatics in the international markets and their related impacts on the domestic market.

19


In dollar terms, net revenue in 2Q07 amounted to US$ 1.6 billion, compared to US$ 1.4 billion in 1Q07, and net revenue in 1H07 was US$ 2.9 billion, 16% higher than the US$ 2.5 billion posted in 1H06.

8.4 Cost of Goods Sold (CoGS)

In the second quarter of 2007, cost of goods sold (CoGS) was R$ 2.6 billion, increasing by 12% from 1Q07. The higher volumes sold and cost of raw materials adversely impacted CoGS, which were partly offset by the improved productivity at our plants and the average appreciation in the Brazilian real of 6%.

The rise in naphtha prices, as mentioned above, and the higher volume consumed led to a naphtha cost R$ 224 million (or 18%) higher in 2Q07 than in 1Q07.

During 2Q07 Braskem purchased 1,078 thousand tons of naphtha, of which 804 thousand tons (75%) from Petrobras, its main supplier of this raw material. The remaining 274 thousand tons (25%) were directly imported by the Company, mostly from North Africa.

Depreciation and amortization expenses totaled R$ 136 million in 2Q07, above prior quarter levels, due to the higher volume sold in 2Q07.


8.5 Selling, General and Administrative Expenses (SG&A)

In 2Q07, selling, general and administrative expenses were R$ 244 million, down R$ 11 million from 1Q07.

In 2Q07, general and administrative expenses were R$ 150 million, up from R$ 125 million in 1Q07. This increase was mainly related to non-recurring revenue in 1Q07 of R$ 17 million involving the adjustment of the provision for future disbursements by Braskem in the event of liquidation of the Petros plan, which involves Braskem employees formerly employed by Copene.

Compared to 2Q06, general and administrative expenses rose by R$ 17 million, mostly driven by: (i) higher personnel expenses from the annual wage increase in 4Q06 under the collective bargaining agreement; and (ii) higher expenses with auditing.

Braskem selling expenses amounted to R$ 95 million in the quarter, down R$ 35 million from 1Q07, mainly attributable to the provision for doubtful accounts, given the recovery of a credit of R$ 13 million in 2Q07, compared to an expense with this provision of R$ 22 million in 1Q07.

Compared to 2Q06, selling expenses were R$ 11 million higher, due to the higher export volumes in 2Q07.

8.6 EBITDA

Braskem EBITDA in 2Q07 rose to R$ 560 million with 17.9% margin over net revenue, representing an increase of 121% from the EBITDA of R$ 253 million and margin of 8.9% in 2Q06. The better operating performance demonstrated by the higher capacity utilization rates, higher sales volume, and improved profitability of our products were the main factors driving this improvement in performance. The 2Q07 result was also positively impacted by non-recurring revenue of R$ 111 million from the reversal of the provision for a PIS/COFINS tax claim with final judgment. In dollar terms, EBITDA rose to US$ 282 million, or US$ 227 million excluding the non-recurring revenue.

20


Compared to 1Q07, EBITDA rose 30% in the quarter, as a result of improved sales volumes and prices and recognition of non-recurring revenue of R$ 111 million, which was partly offset by naphtha prices 14% higher in R$/ton.

8.7 Investments in Subsidiary and Affiliated Companies

Equity in the earnings of subsidiary and affiliated companies in the second quarter of 2007 was R$ 31 million, compared to R$ 38 million in the previous quarter. Excluding the effect of amortization and goodwill arising mainly from the investments in Ipiranga Química, Copesul and Petroflex, the 2Q07 figure was R$ 46 million, down R$ 15 million from 1Q07, primarily due to the lower results posted by Copesul in the period. Amortization of goodwill decreased by R$ 8 million, impacted by the merger of Politeno in April 2007, which transferred amortization of approximately R$ 15 million to the expenses with depreciation and amortization line, as well as by the goodwill on the investment in Ipiranga Química, also as from April, in the amount of R$ 14 million in the quarter.

(R$ thousand)
Investments in Subsidiaries and Associated
 Companies 
   2Q07    1Q07    2Q06    1H07    1H06* 
         
         
         
 
Associated Companies - Equity Method    49,108    62,124    42,096    111,232    104,595 
• Copesul    30,366    56,237    37,672    86,603    98,787 
• Ipiranga    11,489        11,489   
• Others    7,253    5,887    4,424    13,140    5,808 
Exchange Variation     (3,892)    (2,808)   (366)   (6,701)   (218)
 Others    747    1,240    3,730    1,986    2,228 
           
Subtotal (before amortization)   45,962    60,556    45,460    106,518    106,605 
Amortization of goodwill/negative goodwill    (14,963)   (22,674)   26,024    (37,637)   (12,409)
                     
     
TOTAL    30,999    37,882    71,484    68,881    94,196 
     
* Includes 100% of Politeno at 1Q06 

8.7.1 Potential Sale of Petroflex

Braskem, Petroflex and its other controlling shareholders, announced to the Market in May and June that they received a proposal from investors interested in acquiring their shares. The proposals are currently being analyzed and the related negotiations have advanced considerably. However, as of this moment, the interested parties have not reached any determination of the final terms and conditions of any sale transaction. The market will be informed immediately of any developments in the negotiations.

8.8 Net Financial Result

The net financial result in 2Q07 was an expense of R$ 59 million, compared to an expense of R$ 113 million in 1Q07, representing a 48% reduction. The appreciation in the real against the dollar positively impacted financial results in 2Q07 in the foreign exchange variation line in the amount of R$ 91 million.

Excluding the effects of foreign exchange and monetary variation, the net financial result was an expense of R$ 223 million, up 10% on 1Q07, when a R$ 203 million expense was recorded, and up 43% against the same period a year ago, when a R$ 156 million expense was recorded.

The R$ 20 million increase observed in 2Q07 compared to the previous quarter was mainly attributable to higher interest and expenses on vendor transactions, on account of the new financing contracted in the period, mainly the bridge loan, in the amount of R$ 652 million, related to the first step in the process of acquisition of Grupo Ipiranga petrochemical assets. The conversion of the debentures held by Odebrecht and the following reduction on gross debt only happened by the end of the quarter and thus interest expenses were impacted by that debt during 2Q07.

Compared to the 2Q06 results and excluding the effects of foreign exchange and monetary variation, the increase was equal to R$ 67 million. The change was mainly driven by the R$ 19 million increase in interest and vendor transaction expenses arising from higher indebtedness in 2Q07 before the conversion of debentures and the R$ 25 million increase in Other financial expenses due to expenses with derivative (hedge) contracts and commissions on financing, in addition to a change in the investment profile, with an impact of R$ 24 million.

21


The following tables show the composition of Braskem financial results on a quarterly basis.     
   (R$ million)                    
    2Q07    1Q07    2Q06    1H07    1H06* 
   Financial Expenses    30    (81)   (302)   (51)   (287)
                     Interest / Vendor    (131)   (111)   (112)   (242)   (235)
                     Monetary Variation    (62)   (63)   (61)   (125)   (119)
                     Foreign Exchange Variation    337    196    (39)   532    261 
                     CPMF/IOF/Income Tax/Banking Expenses    (29)   (21)   (29)   (50)   (49)
                     Interest on Fiscal Provisions    (25)   (27)   (27)   (52)   (71)
                     Other    (60)   (54)   (35)   (114)   (74)
   Financial Revenue    (90)   (31)   51    (121)   (51)
                     Interest    22    11    46    32    84 
                     Monetary Variation    3    21    4    24    6 
                     Foreign Exchange Variation    (114)   (63)   1    (177)   (142)
 
                     
   Net Financial Result    (59)   (113)   (252)   (172)   (338)
                     

(R$ million)                    
    2Q07    1Q07    2Q06    1H07    1H06* 
Financial Result excluding F/X and MV    (223)   (203)   (156)   (426)   (344)
Foreign Exchange and Monetary Variations:                     
 
Foreign Exchange Variation (F/X)   223    132    (39)   355    119 
Monetary Variation (MV)   (59)   (42)   (57)   (101)   (113)
                     
Net Financial Result    (59)   (113)   (252)   (172)   (338)
                     

 
*Includes 100% of Politeno at 1Q06

8.9. Free Cash Flow

Braskem operating cash generation was an R$ 123 million debit in 2Q07, compared to an R$ 850 million credit in 1Q07. The reason for the variation is the change in working capital arising from the integration with Copesul, and the redemption of financial investments for cash availability purposes in the prior quarter. The higher investment in 2Q07 was due to the acquisition of the petrochemical assets of the Ipiranga Group in April.

R$ million    2Q07    1Q07    2Q06    1H07    1H06* 
 
Operating Cash Flow    (123)   850    0    727    (12)
 
Interest paid    (119)   (92)   (93)   (211)   (168)
Investment Activities    (916)   (151)   (463)   (1,067)   (638)
Share Buy-back           -    (57)     (57)
Taxes paid    (4)   (3)   (7)   (7)   (13)
 
Free Cash Flow (FCF)   (1,162)   605    (620)   (557)   (887)

 
*Includes 100% of Politeno at 1Q06

8.10 Capital Structure and Liquidity

Gross debt amounted to R$ 5.2 billion as of June 30, 2007, declining by 10% or R$ 589 million compared to March 31, 2007. The reduction is attributable to the conversion into Braskem shares of Braskem debentures held by Odebrecht, leading to a decline of R$ 1.2 billion, partly offset by the debt incurred in connection with the 1st installment of the payment for the petrochemical assets of the Ipiranga Group in the amount of R$ 652 million. Cash and cash equivalents, in turn, declined by approximately R$ 365 million, on account of the disbursement associated with the acquisition and changes in working capital arising from the merger of Braskem, Ipiranga Petroquímica and Copesul.

As a result, Braskem net debt on June 30 was R$ 4.0 billion, R$ 224 million less than R$ 4.2 billion recorded as of March 31, 2007. In dollar terms, net debt remained virtually unchanged, amounting to US$ 2.1 billion on June 30, 2007, due to the 6% appreciation of the real during the period.

22


The Company's financial leverage as measured by the ratio of Net Debt to EBITDA, which corresponded to 2.5x at the end of 1Q07 (past 12 months), declined by 20% at the end of 2Q07 (past 12 months) to 2x. The average debt term is 18 years, which enables the Company to maintain an adequate annual maturity profile, as well as more efficiently allocate funds to operating working capital. At the end of June 2007, the dollar-linked debt registered relative growth, since the debt in denominated in Brazilian real was reduced by the conversion of the debentures held by Odebrecht. Accordingly, this percentage, which was 51% on March 31, 2007, stood at 69% at June 30, 2007.

The chart below depicts the Company's repayment schedule as of June 30, 2007. Note that the balance of cash and cash equivalents on that date was higher than the maturity of short-term debt (R$ 274 million).


23


9. EXHIBITS LIST:

        Page
EXHIBIT I –    Consolidated Income Statement    25 
EXHIBIT II –    Consolidated Income Statement by Company    26 
EXHIBIT III –    Consolidated Balance Sheet    27 
EXHIBIT IV –    Consolidated Cash Flow    28 
EXHIBIT V –    Consolidated Sales Volume – Domestic Market    29 
EXHIBIT VI –    Consolidated Sales Volume – Export Market    30 
EXHIBIT VII    Consolidated Net Revenue – Domestic Market    31 
EXHIBIT VIII    Consolidated Net Revenue – Export Market    32 
EXHIBIT IX -    Braskem Income Statement    33 
EXHIBIT X –    Braskem Balance Sheet    34 
EXHIBIT XI –    Braskem Cash Flow    35 
EXHIBIT XII -    Braskem Sales Volume – Domestic Market    36 
EXHIBIT XIII–    Braskem Sales Volume – Export Market    37 
EXHIBIT XIV –    Braskem Net Revenue – Domestic Market    38 
EXHIBIT XV -    Braskem Net Revenue – Export Market    39 
EXHIBIT XVI –    Copesul Income Statement    40 
EXHIBIT XVII -    Copesul Balance Sheet    41 
EXHIBIT XVIII    Copesul Cash Flow    42 
EXHIBIT XIX -    Copesul Production, Sales Volume and Net Revenue    43 
EXHIBIT XX –    Ipiranga Petroquímica Income Statement    44 
EXHIBIT XXI –    Ipiranga Petroquímica Balance Sheet    45 
EXHIBIT XXII –   Ipiranga Petroquímica Cash Flow    46 
EXHIBIT XXIII –   Ipiranga Petroquímica Production, Sales Volume and Net Revenue    47 

Braskem, a world-class Brazilian petrochemical company, is the leader in the thermoplastic resins segment in Latin America, and is the second largest Brazilian industrial company owned by the private sector. The company operates 18 manufacturing plants located throughout Brazil, and has an annual production capacity of 10 million tons of petrochemical and chemical products. 

Forward-Looking Statement Disclaimer for U.S. Securities Law Purposes

This press release contains statements that are forward-looking within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements are only predictions and are not guarantees of future performance. Investors are cautioned that any such forward-looking statements are and will be, as the case may be, subject to many risks, uncertainties and factors relating to the operations and business environments of Braskem and its subsidiaries that may cause the actual results of the companies to be materially different from any future results expressed or implied in such forward-looking statements.

Factors that could cause actual results to differ materially from these forward-looking statements include, but are not limited to, the risks and uncertainties set forth from time to time in Braskem reports filed with the United States Securities and Exchange Commission. Although Braskem believes that the expectations and assumptions reflected in the forward-looking statements are reasonable based on information currently available to Braskem management, Braskem cannot guarantee future results or events. Braskem expressly disclaims a duty to update any of the forward-looking statements.

24


EXHIBIT I
Consolidated Income Statement (1)

(R$ million)

Income Statement    2Q07
(A)
  1Q07
(B)
  2Q06
(C)
  Change  (%)
(A)/(B)
  Change
(%)
(A)/(C)
  1H07
(D)
  1H06*
(E)
  Change
(%)
(D)/(E)
Gross revenue    6,161    5,620    5,194    10    19    11,781    10,306    14 
Net revenue    4,969    4,424    4,048    12    23    9,393    8,022    17 
Cost of goods sold    (4,037)   (3,412)   (3,435)   18    18    (7,449)   (6,700)   11 
Gross profit    932    1,012    613    (8)   52    1,944    1,322    47 
Selling expenses    (128)   (168)   (112)   (24)   13    (295)   (225)   31 
General and Administrative expenses    (205)   (176)   (174)   17    18    (382)   (324)   18 
Depreciation and amortization    (122)   (108)   (106)   14    16    (230)   (194)   18 
Other operating income (expenses)   120    (4)   25      383    116    126    (9)
Investments in Associated Companies    (22)   (35)   29    (38)     (57)   14   
  •Equity Result        18    (73)   (98)     56    (96)
  •Amortization of goodwill/negative goodwill    (22)   (37)   11    (40)     (59)   (42)   40 
Operating profit before financial result    575    521    274    10    110    1,096    719    52 
Net financial result    (59)   (104)   (317)   (43)   (81)   (163)   (357)   (54)
Operating profit (loss)   516    417    (42)   24      933    362    158 
Other non-operating revenue (expenses)   (22)   (4)     503      (25)   (2)   1,351 
Profit (loss) before income tax and social contribution    494    413    (39)   20      908    360    152 
Income tax / social contribution    (70)   (138)   79    (49)     (208)   (44)   368 
Profit Sharing    (5)           (5)    
Profit (loss) before minority interest    420    275    40    52    943    695    316    120 
Minority Interest    (138)   (148)   (95)   (7)   46    (287)   (224)   28 
Net profit (loss)   281    127    (55)   121      408    92    344 
 
                                 
 
EBITDA    921    853    562      64    1,774    1,290    37 
EBITDA Margin    18.5%    19.3%    13.9%    -0,8p.p.    +4,6 p.p.    18.9%    16.1%    +2,8 p.p. 
-Depreciacion and Amortization    324    297    317        621    585   
   • Cost    202    189    211      (4)   391    391    (0)
   • Expense    122    108    106    14    16    230    194    18 
 

(1) Consider the effects of the acquisition of the petroche
mical assets from the Ipiranga Group since January 1, 2006 
* Includes 100% of Politeno at 1Q06 

25

EXHIBIT II
Consolidated Income Statement by Company

(R$ million)

Income Statement    Braskem
2Q07
 
  Ipiranga
Effect
 
  Copesul
Effect
 
  CVM 247   Eliminations   Braskem Consolidated 2Q07
Gross revenue    4,007    759    2,501    104    (1,211)   6,161 
Net revenue    3,133    585    2,058    86    (893)   4,969 
Cost of goods sold    (2,569)   (490)   (1,790)   (70)   883    (4,037)
Gross profit    564    95    267    15    (10)   932 
Selling expenses    (95)   (21)   (10)   (3)     (128)
General and Administrative expenses    (150)   (25)   (27)   (3)     (205)
Depreciation and amortization    (116)   (3)   (3)   (0)     (122)
Other operating income (expenses)   104    14          120 
Investments in Associated Companies    31    134        (187)   (22)
  •Equity Result    46    141        (187)  
  •Amortization of goodwill/negative goodwill    (15)   (7)         (22)
Operating profit before financial result    338    194    229    10    (197)   575 
Net financial result    (59)     (2)   (1)     (59)
Operating profit (loss)   279    197    227      (197)   516 
Other non-operating revenue (expenses)   (23)     (4)   (0)     (22)
Profit (loss) before income tax and social contribution    256    202    224      (197)   494 
Income tax / social contribution    25    (17)   (75)   (3)     (70)
Profit Sharing        (5)       (5)
Profit (loss) before minority interest    281    185    144      (197)   420 
Minority Interest    (0)   (0)       (138)   (138)
Net profit (loss)   281    185    144      (335)   281 
 
 
 
EBITDA    560    70    288    13    (10)   921 
EBITDA Margin    17.9%    12.0%    14.0%    15.4%    1.1%    18.5% 
-Depreciacion and Amortization    253    10    59        324 
  • Cost    136      56        202 
  • Expense    116            122 
 
The R$ 138 milion in minority interest include: R$79 milion of Ipiranga Química (which includes Ipiranga Petroquímica results) and R$ 59 million of Copesul.

26


EXHIBIT III
Consolidated Balance Sheet
(R$ million)
     

ASSETS    06/30/2007
(A)
  03/31/2006
(B)
  Change (%)(A)/(B)
Current Assets    7,122    7,210    (1)
   • Cash and Cash Equivalents    2,087    2,087    - 
   • Account Receivable    1,831    1,866    (2)
   • Inventories    2,375    2,423    (2)
   •. Recoverable Taxes    536    475    13 
   • Dividends/Interest on Owners' Equity    2    49    (96)
   • Advances to Suppliers    79    85    (7)
   • Others    213    224    (5)
Long-Term Assets    1,997    1,967     2 
   • Related Parties    43    42    2 
   • Compulsory Deposits and Escrow accounts    127    89    43 
   • Deferred income taxes and social contribution    544    519    5 
   • Recoverable Taxes    1,045    1,174    (11)
   • Others    239    143    67 
Fixed Assets    10,813    10,848    (0)
   •Investments    616    631    (2)
   •Plant, property and equipment    8,254    8,164    1 
   •Deferred    1,943    2,053    (5)
 
Total Assets    19,932    20,024    (1)
 
 
LIABILITIES AND SHAREHOLDERS' EQUITY    06/30/2007
(A)
  03/31/2006
(B)
  Change (%)
(A)/(B)
Current    5,309    6,906    (23)
   • Suppliers    2,790    2,769    1 
   • Short-term financing    1,511    3,130*    (52)
   • Salaries and social charges    177    213    (17)
   • Dividends/Interest on Owners' Equity    8    96    (91)
   • Income Tax Payable    197    118    66 
   • Receivable Taxes    306    189    62 
   • Advances from Clients    41    21    101 
   • Others    279    371    (25)
Long-Term Liabilities    7,424    7,436    - 
   • Long-term financing    5,793    5,819    (1)
   • Taxes Payable    1,417    1,423    - 
   • Others    213    194    10 
Deferred Income    28    29    (4)
Minority Interest    1,327    1,198    11 
Shareholders' Equity    5,844    4,454    31 
   • Capital    3,527    3,508    1 
   • Adjustment for Future Capital Increase**    1,104    -    - 
   • Capital Reserves    436    419    4 
   • Treasury Shares    (258)   (256)   1 
   • Profit reserve    651    663    (2)
   • Retained Earnings (Losses)   384    119    222 
 
Total Liabilities and Shareholders' Equity    19,932    20,024    (1)
 

* Includes convertible debentures totally subscribed by Odebrecht in the amount of R$ 1,162 million.

**Corresponds to the conversion of Braskem debentures held by Odebrecht in voting and preferred Braskem shares. Amount net of income tax on interest.

27


EXHIBIT IV
Consolidated Cash Flow

(R$ million)

Cash Flow

  2Q07    1Q07    2Q06    1H07    1H06* 
Net Income for the Period    281    127    (55)   408    92 
Expenses (Revenues) not affecting Cash    266    452    422    718    743 
 Depreciation and Amortization    324    297    317    620    585 
 Equity Result    22    35    (29)   57    (14)
 Interest, Monetary and Exchange Restatement, Net    (116)   (24)   158    (140)   116 
 Minority Interest    138    148    95    287    224 
 Others    (102)   (4)   (118)   (106)   (168)
Adjusted Profit (loss) before cash financial effects    547    579    368    1,126    835 
Cash impact from Ipiranga Acquisition    (1)   -    0    (1)   140 
Asset and Liabilities Variation, Current and Long Term    208    533    62    741    (159)
Asset Reductions (Additions)   127    724    (157)   851    (444)
           
 Marketable Securities    (3)   367    (32)   364    (130)
 Account Payable    82    216    (101)   298    (177)
 Recoverable Taxes    33    35    (112)   68    (185)
 Inventories    47    (37)   (74)   10    (85)
 Advances Expenses    17    18    13    36    22 
 Dividends Received    (0)   83    191    83    237 
 Other Account Receivables    (49)   42    (41)   (7)   (126)
Liabilities Additions (Reductions)   81    (191)   219    (110)   285 
           
 Suppliers    64    (189)   12    (125)   73 
 Advances to Clients    (1)     (19)     (24)
 Fiscal Incentives    17    14    13    31    48 
 Taxes and Contributions    18      11    24    (45)
 Others    (18)   (22)   202    (40)   232 
Cash resulting from operating activities    754    1,112    430    1,866    817 
Investment Activities    (1,114)   (224)   (494)   (1,338)   (696)
 Alienação de Ativos Permanente           
 Investment    (785)     (237)   (785)   (237)
 Fixed Assets    (324)   (218)   (229)   (542)   (426)
 Deferred Assets    (5)   (7)   (28)   (12)   (33)
Subsidiaries and Affiliated Companies, Net    131    (45)   92    86    60 
Financing Activities    266    (677)   (816)   (411)   (918)
 Inflows    2,939    693    1,887    3,633    2,764 
 Amortization and Paid Interest    (2,644)   (1,170)   (1,931)   (3,813)   (2,784)
 Share Buy-Back        (57)     (57)
 Dividend/Interest attributable to Shareholders    (29)   (201)   (565)   (230)   (689)
 Others      (0)   (150)   (0)   (153)
 
 Cash and Cash Equivalents Increase (Reduction)   38    165    (788)   204    (737)
Cash and Cash Equivalents at the beginning of period    1,882    1,717    2,189    1,717    2,138 
Cash and Marketable Securities at the end of period    1,920    1,882    1,402    1,920    1,402 
 
* Considers 100% of Politeno at 1Q06 

28


EXHIBIT V
Consolidated Sales Volume – Domestic Market

DOMESTIC MARKET - Sales Volume 
                         
tons    1Q06*    2Q06    3Q06    4Q06    1Q07    2Q07 
 
Polyolefins Unit                         
   • PE´s - Polyethylene    249,819    250,531    254,151    200,568    227,553    248,365 
   • PP - Polypropylene    140,729    151,330    161,744    123,187    141,496    153,858 
   • Total (PE´s + PP)   390,548    401,861    415,895    323,755    369,049    402,222 
 
Vinyls Unit                         
   • PVC - Polyvinyl Chloride    98,914    95,361    109,647    96,434    102,647    110,278 
   • Caustic Soda    104,757    100,485    106,608    109,872    102,818    108,999 
   • EDC             
   • Chlorine    14,002    14,499    15,163    15,064    15,333    15,040 
 
Basic Petrochemical Unit                     
   • Ethylene    112,076    110,439    108,105    116,315    118,957    117,850 
   • Propylene    90,143    83,865    91,520    76,001    90,604    98,988 
   • Benzene    85,275    88,109    77,127    86,071    83,173    82,697 
   • Butadiene    42,010    51,312    56,556    51,426    52,187    44,316 
   • Toluene    7,921    7,854    8,172    10,810    9,775    5,849 
   • Fuel (m3)   147,192    202,909    159,763    167,487    147,276    112,234 
   • Para-xylene    14,940    9,155    16,425       
   • Ortho-xylene    13,241    15,146    16,749    16,518    14,522    16,885 
   • Isoprene    3,290    4,226    3,436    1,859    2,227    1,476 
   • Butene 1    5,875    6,030    6,554    5,962    5,946    5,346 
   • Mixed Xylene    17,310    11,751    16,256    15,917    13,476    15,971 
 
Business Development                         
   • PET    9,152    11,297    14,957    15,180    17,475    14,057 
   • Caprolactam    8,927    8,501    4,862    3,445    4,307    4,664 
 
* Considers 100% of Politeno 

29


EXHIBIT VI
Consolidated Sales Volume – Export Market

EXPORT MARKET - Sales Volume
                         
tons     1Q06*    2Q06    3Q06    4Q06    1Q07    2Q07 
 
Polyolefins Unit                         
   • PE´s - Polyethylene    121,675    155,427    149,647    187,435    160,533    174,567 
   • PP - Polypropylene    20,037    19,455    21,775    41,076    27,499    40,616 
   • Total (PE´s + PP)   141,712    174,882    171,422    228,511    188,032    215,183 
 
Vinyls Unit                         
   • PVC - Polyvinyl Chloride    12,831    8,309    6,958    4,300    17,455    10,872 
   • Caustic Soda          6,220    4,113   
   • EDC    38,980    34,145    17,969    13,002    36,190    12,373 
   • Chlorine             
 
Basic Petrochemical Unit                         
   • Ethylene        7,593    7,021    9,616    9,155 
   • Propylene    29,606    25,359    29,261    25,277    24,553    29,828 
   • Benzene    65,202    65,119    82,544    88,594    84,528    87,206 
   • Butadiene    22,144    14,163    8,839    11,437    9,821    12,269 
   • Toluene              10,496 
   • Fuel (m3)     11,554    49,199      15,614    50,905 
   • Para-xylene      13,226    5,248    20,096    23,507    14,695 
   • Ortho-xylene    2,087    4,093    3,556    4,192    4,193   
   • Isoprene    13    14    14    14      830 
   • Butene 1    5,321    1,599    6,929    4,879    2,809    6,836 
   • Mixed Xylene    6,912    12,152    10,798    4,263    14,286    19,934 
 
Business Development                         
   • PET    425    10,650    1,304    1,000    353    249 
   • Caprolactam    4,771    2,871    4,860    5,250    7,788    4,675 
 
* Considers 100% of Politeno 

30


EXHIBIT VII
Consolidated Net Revenue – Domestic Market
(R$ million)

DOMESTIC MARKET - Net Revenue
                         
R$ million    1Q06*    2Q06    3Q06    4Q06    1Q07    2Q07 
 
Polyolefins Unit                         
   • PE´s - Polyethylene    787    747    844    737    789    855 
   • PP - Polypropylene    449    475    558    451    497    529 
   • Total (PE´s + PP)   1,235    1,222    1,402    1,188    1,286    1,384 
 
Vinyls Unit                         
   • PVC - Polyvinyl Chloride    245    228    278    257    255    276 
   • Caustic Soda    101    85    85    84    82    88 
   • EDC       -     -     -     -   
   • Chlorine             
 
Basic Petrochemical Unit                         
   • Ethylene    253    257    258    267    273    268 
   • Propylene    188    162    209    163    181    212 
   • Benzene    127    149    182    198    180    191 
   • Butadiene    97    114    139    133    126    105 
   • Toluene    12    14    18    18    18    12 
   • Fuel    145    208    159    164    142    109 
   • Para-xylene    31    20    47    (0)          -           - 
   • Ortho-xylene    26    30    41    39    32    39 
   • Isoprene    17    23    19    12    11   
   • Butene 1    14    14    18    15    15    13 
   • Mixed Xylene    33    24    41    37    29    37 
 
Business Development                         
   • PET    27    33    46    47    54    40 
   • Caprolactam    42    41    25    19    25    26 
 
Resale of Condensate                       -           -      81    188    367 
Ipiranga Química    112    61    95    98    113    94 
Others    406    271    350    149    339    354 
 
 
Total    3,116    2,964    3,420    2,979    3,357    3,630 
* Considers 100% of Politeno 

31


EXHIBIT VIII
Consolidated Net Revenue – Export Market
(R$ million)

EXPORT MARKET - Net Revenue
                         
R$ million    1Q06*    2Q06    3Q06    4Q06    1Q07    2Q07 
 
Polyolefins Unit                         
   • PE´s - Polyethylene    328    404    454    509    447    478 
   • PP - Polypropylene    48    50    61    106    73    106 
   • Total (PE´s + PP)   376    455    515    615    520    584 
 
Vinyls Unit                         
   • PVC - Polyvinyl Chloride    23    16    15    10    34    22 
   • Caustic Soda               -               - 
   • EDC    14    17    12    10    26   
   • Chlorine             
 
Basic Petrochemical Unit                         
   • Ethylene        17    17    20    18 
   • Propylene    49    43    54    53    45    57 
   • Benzene    109    117    193    191    185    194 
   • Butadiene    42    30    21    28    22    27 
   • Toluene              17 
   • Fuel      14    60      13    55 
   • Para-xylene      28    12    45    49    33 
   • Ortho-xylene             
   • Isoprene             
   • Butene 1    10      14        13 
   • Mixed Xylene      21    18      18    32 
 
Business Development                         
   • PET      29         
   • Caprolactam    20    12    22    24    36    23 
 
Resale of Condensate        83        77 
Ipiranga Química             
Others    201    291    255    222    82    173 
 
 
Total    858    1,084    1,304    1,244    1,067    1,338 

* Considers 100% of Politeno 

32


     EXHIBIT IX Braskem Income Statement (R$ million)

Income Statement    2Q07
(A)
  1Q07
(B)
  2Q06
(C)
  Change
(%)
(A)/(B)
  Change
(%)
(A)/(C)
  1H07
(D)
  1H06*
(E)
  Change
(%)
(D)/(E)
Gross revenue    4,007    3,716    3,650      10    7,723    7,168   
Net revenue    3,133    2,865    2,832      11    5,998    5,560   
Cost of goods sold    (2,569)   (2,302)   (2,531)   12      (4,872)   (4,855)  
Gross profit    564    562    302      87    1,126    706    60 
Selling expenses    (95)   (129)   (83)   (27)   14    (224)   (165)   36 
General and Administrative expenses    (150)   (125)   (133)   19    13    (275)   (246)   12 
Depreciation and amortization    (116)   (102)   (102)   14    14    (218)   (185)   18 
Other operating income (expenses)   104    (0)   21      389    103    112    (8)
Investments in Associated Companies    31    38    71    (18)   (57)   69    94    (27)
  •Equity Result    46    61    45    (24)     107    107    (0)
  •Amortization of goodwill/negative goodwill    (15)   (23)   26    (34)     (38)   (12)   203 
Operating profit before financial result    338    243    76    39    343    581    316    84 
Net financial result    (59)   (113)   (252)   (48)   (77)   (172)   (338)   (49)
Operating profit (loss)   279    130    (175)   114      409    (22)  
Other non-operating revenue (expenses)   (23)   (1)     2,291      (24)    
Profit (loss) before income tax and social contribution    256    130    (172)   98      386    (19)  
Income tax / social contribution    25    (23)   120      (80)     91    (98)
Profit (loss) before minority interest    281    107    (52)   163      388    72    441 
Minority Interest    (0)   (0)   (2)       (0)   (1)   (99)
Net profit (loss)   281    107    (54)   163      388    71    449 
 
 
 
EBITDA    560    432    253    30    121    992    670    48 
EBITDA Margin    17.9%    15.1%    8.9%    +2,8 p.p.    +9,0 p.p.    16.5%    12.1%    +4,4 p.p. 
-Depreciacion and Amortization    253    227    249    11      479    448   
  • Cost    136    125    147      (7)   261    263    (1)
  • Expense    116    102    102    14    14    218    185    18 
 
* Considers 100% of Politeno at 1Q06 

33


EXHIBIT X
Braskem Balance Sheet
(R$ million)

ASSETS    06/30/2007
(A)
  03/31/2007
(B)
  Change (%)
(A)/(B)
Current Assets    4,553    4,994    (9)
 • Cash and Cash Equivalents    1,231    1,596    (23)
 • Account Receivable    1,271    1,241    2 
 • Inventories    1,548    1,635    (5)
 • Recoverable Taxes    295    313    (6)
 • Dividends/Interest on Owners' Equity    2    2    - 
 • Expenses paid in advance    57    67    (15)
 • Others    150    140    7 
Long-Term Assets    1,558    1,525             2 
   • Related Parties    43    42    2 
   • Compulsory Deposits    104    75    39 
   • Deferred income taxes and social    391    366    7 
   • Recoverable Taxes    906    921    (2)
   • Others    115    121    (5)
Fixed Assets    9,560    8,858             8 
   •Investments    1,553    846    83 
   •Plant, property and equipment    6,441    6,364    1 
   •Deferred    1,566    1,647    (5)
 
Total Assets    15,671    15,376             2 
 
 
 
 LIABILITIES AND SHAREHOLDERS' EQUITY    06/30/2007
(A)
  03/31/2007
(B)
  Change (%)
(A)/(B)
Current    3,364    5,173    (35)
 • Suppliers    2,478    2,983    (17)
 • Short-term financing    274    1,577*    (83)
 • Salaries and social charges    123    178    (31)
 • Dividends/Interest on Owners' Equity    4    40    (90)
 • Income Tax Payable    6    5    22 
 • Receivable Taxes    207    106    95 
 • Advances from Clients    25    19    28 
 • Others    248    265    (6)
Long-Term Liabilities    6,394    5,688    12 
 • Long-term financing    4,937    4,223    17 
 • Taxes Payable    1,304    1,316    (1)
 • Others    152    149    2 
Deferred Income    27    29    (4)
Minority Interest    2    22    (90)
Shareholders' Equity    5,883    4,464    32 
 • Capital    3,527    3,508    1 
 • Adjustment for Future Capital Increase    1,104    0    - 
 • Capital Reserves    436    419    4 
 • Treasury Shares    (258)   (256)   1 
 • Profit reserve    685    685    - 
 • Retained Earnings (Losses)   388    107    263 
 
Total Liabilities and Shareholders' Equity    15,671    15,376             2 
 
* Includes R$1,162 million from convertible debentures fully subscribed by Odebrecht 

Suppliers reduction is driven by a change in working capital derived from the acquisition of Grupo Ipiranga petrochemical assets.

34


EXHIBIT XI
Braskem Cash Flow

(R$ million)

Cash Flow    2Q07    1Q07    2Q06     1H07    1H06* 
Net Income for the Period    281    107    (54)   388    71 
Expenses (Revenues) not affecting Cash    17    190    196    207    361 
 Depreciation and Amortization    253    227    244    479    444 
 Equity Result    (31)   (38)   (72)   (69)   (94)
 Interest, Monetary and Exchange Restatement, Net    (82)   10    124    (72)   174 
 Minority Interest           
 Others    (122)   (9)   (103)   (131)   (163)
Adjusted Profit (loss) before cash financial effects    298    297    142    595    432 
Cash impact from Ipiranga Acquisition    (1)   0    0    (1)   0 
Asset and Liabilities Variation, Current and Long Term    (420)   554    (142)   133    (443)
Asset Reductions (Additions)   147    699    (131)   846    (355)
           
 Marketable Securities    (3)   380    (11)   377    (91)
 Account Payable    (10)   249    (87)   239    (101)
 Recoverable Taxes    33    33    (111)   66    (183)
 Inventories    66    (42)   (6)   25    (92)
 Advances Expenses    17    20    12    37    22 
 Dividends Received      60    81    60    109 
 Other Account Receivables    44    (1)   (10)   43    (20)
Liabilities Additions (Reductions)   (568)   (145)   (10)   (713)   (88)
           
 Suppliers    (510)   (122)     (632)   (39)
 Advances to Clients    (1)     (20)   (0)   (24)
 Fiscal Incentives    17    11    (6)   28   
 Taxes and Contributions    16        25    (47)
 Others    (90)   (44)   (1)   (133)   18 
Cash resulting from operating activities    (123)   850    0    727    (12)
Investment Activities    (916)   (151)   (463)   (1,067)   (638)
 Investment    (687)     (237)   (687)   (237)
 Fixed Assets    (229)   (149)   (200)   (378)   (370)
 Deferred Assets    (1)   (2)   (27)   (2)   (32)
Subsidiaries and Affiliated Companies, Net    (1)   (0)   (4)   (1)   (5)
Financing Activities    693    (570)   (317)   122    (301)
 Inflows    1,559    250    1,460    1,809    1,952 
 Amortization and Paid Interest    (830)   (819)   (1,392)   (1,649)   (1,834)
 Share Buy-Back        (57)     (57)
 Dividend/Interest attributable to Shareholders    (37)   (1)   (328)   (37)   (363)
 
 Cash and Cash Equivalents Increase (Reduction)   (347)   129    (784)   (218)   (956)
Cash and Cash Equivalents at the beginning of period    1,528    1,399    1,914    1,399    2,086 
Cash and Marketable Securities at the end of period    1,181    1,528    1,130    1,181    1,130 
 
* Considers 100% of Politeno at 1Q06 

35


EXHIBIT XII
Braskem Sales Volume – Domestic Market

DOMESTIC MARKET - Sales Volume 
                         
tons     1Q06*    2Q06    3Q06    4Q06    1Q07    2Q07 
 
Polyolefins Unit                         
   • PE´s - Polyethylene    176,336    180,328    178,271    137,026    157,837    184,269 
   • PP - Polypropylene    108,761    119,469    128,347    96,657    111,652    127,929 
   • Total (PE´s + PP)   285,098    299,797    306,618    233,683    269,489    312,198 
 
Vinyls Unit                         
   • PVC - Polyvinyl Chloride    98,914    95,361    109,647    96,434    102,647    110,278 
   • Caustic Soda    105,351    101,189    107,190    110,125    103,305    109,349 
   • EDC             
   • Chlorine    14,002    14,499    15,163    15,064    15,333    15,040 
 
Basic Petrochemical Unit                         
   • Ethylene    58,485    58,382    52,477    56,629    62,051    60,724 
   • Propylene    86,427    80,827    87,349    71,854    86,704    96,420 
   • Benzene    39,387    38,572    34,172    37,458    38,073    34,111 
   • Butadiene    31,515    38,104    37,947    33,361    37,644    29,136 
   • Toluene    7,921    7,854    8,172    10,810    9,928    5,939 
   • Fuel (m3)   73,594    120,030    76,918    81,826    71,665    53,151 
   • Para-xylene    14,940    9,155    16,425       
   • Ortho-xylene    13,241    15,146    16,749    16,518    14,522    16,885 
   • Isoprene    3,290    4,226    3,436    1,859    2,227    1,476 
   • Butene 1    5,875    5,754    5,768    5,939    5,926    4,264 
   • Mixed Xylene    8,528    7,987    9,461    8,134    9,240    9,979 
 
Business Development                         
   • PET    9,152    11,297    14,957    15,180    17,475    14,057 
   • Caprolactam    8,927    8,501    4,862    3,445    4,307    4,664 
 
* Considers 100% of Politeno 

36


EXHIBIT XIII
Braskem Sales Volume – Export Market

EXPORT MARKET - Sales Volume
                         
tons    1Q06*    2Q06    3Q06    4Q06    1Q07    2Q07 
 
Polyolefins Unit                         
   • PE´s - Polyethylene    80,328    104,719    106,271    118,277    110,552    129,076 
   • PP - Polypropylene    12,858    15,876    19,588    28,389    23,549    27,374 
   • Total (PE´s + PP)   93,186    120,595    125,859    146,666    134,101    156,450 
 
Vinyls Unit                         
   • PVC - Polyvinyl Chlorid    12,831    8,309    6,958    4,300    17,455    10,872 
   • Caustic Soda          6,220    4,113   
   • EDC    38,980    34,145    17,969    13,002    36,190    12,373 
   • Chlorine             
 
Basic Petrochemical Unit                     
   • Ethylene             
   • Propylene    29,606    25,359    29,261    25,277    24,553    29,828 
   • Benzene    41,092    43,396    53,472    52,567    45,579    57,530 
   • Butadiene    6,376    3,200         
   • Toluene              10,496 
   • Fuel (m3)       30,777        14,996 
   • Para-xylene      13,226    5,248    20,096    23,507    14,695 
   • Ortho-xylene    2,087    4,093    3,556    4,192    4,193   
   • Isoprene    13    14    14    14      830 
   • Butene 1    1,540            772 
   • Mixed Xylene    6,885    2,060    3,828      9,219    13,535 
 
Business Development                         
   • PET    425    10,650    1,304    1,000    353    249 
   • Caprolactam    4,771    2,871    4,860    5,250    7,788    4,675 
 
* Considers 100% of Politeno 

37


EXHIBIT XIV
Braskem Net Revenue – Domestic Market
(R$ million)

                                                 DOMESTIC MARKET - Net Revenue 
                         
R$ million    1Q06*    2Q06    3Q06    4Q06    1Q07    2Q07 
 
Polyolefins Unit                         
   • PE´s - Polyethylene    556    534    595    517    549    635 
   • PP - Polypropylene    347    374    444    351    391    437 
   • Total (PE´s + PP)   902    907    1,039    868    941    1,072 
 
Vinyls Unit                         
   • PVC - Polyvinyl Chloride    245    228    278    257    255    276 
   • Caustic Soda    101    86    85    85    83    88 
   • EDC             -           -           -           -           -           - 
   • Chlorine             
 
Basic Petrochemical Unit                         
   • Ethylene    129    139    123    132    139    136 
   • Propylene    179    155    200    153    172    206 
   • Benzene    63    69    80    83    82    76 
   • Butadiene    73    85    95    88    92    70 
   • Toluene    12    14    18    18    18    12 
   • Fuel (m3)   72    124    76    81    68    51 
   • Para-xylene    31    20    47             (0)          -           - 
   • Ortho-xylene    26    30    41    39    32    39 
   • Isoprene    17    23    19    12    11   
   • Butene 1    14    13    16    15    15    11 
   • Mixed Xylene    17    17    25    20    20    23 
 
Business Development                         
   • PET    27    33    46    47    54    40 
   • Caprolactam    42    41    25    19    25    26 
 
Others    188    79    195    196    155    153 
   
Total    2,145    2,072    2,417    2,122    2,171    2,296 
* Considers 100% of Politeno 

38


EXHIBIT XV
Braskem Net Revenue – Export Market
(R$ million)

EXPORT MARKET - Net Revenue
                         
R$ million    1Q06*    2Q06   3Q06    4Q06    1Q07    2Q07 
 
Polyolefins Unit                         
   • PE´s - Polyethylene    208    271    315    325    301    355 
   • PP - Polypropylene    32    41    54    73    61    72 
   • Total (PE´s + PP)   239    313    369    398    362    427 
 
Vinyls Unit                         
   • PVC - Polyvinyl Chloride    23    16    15    10    34    22 
   • Caustic Soda             
   • EDC    14    17    12    10    26   
   • Chlorine             
 
Basic Petrochemical Unit                         
   • Ethylene             
   • Propylene    49    43    54    53    45    57 
   • Benzene    68    76    126    113    101    129 
   • Butadiene    11           
   • Toluene              17 
   • Fuel (m3)       42        20 
   • Para-xylene      28    12    45    49    33 
   • Ortho-xylene             
   • Isoprene             
   • Butene 1             
   • Mixed Xylene            12    22 
 
Business Development                         
   • PET      29         
   • Caprolactam    20    12    22    24    36    23 
 
Others    143    209    191    187    17    73 
   
Total    583    760    860    853    694    838 
* Considers 100% of Politeno 

39


EXHIBIT XVI
Copesul Income Statement
(R$ million)

    2Q07
(A)
  1Q07
(B)
  2Q06
(C)
  Change   Change   1H07 (D)   1H06 (E)   Change 
Income Statement          (%)   (%)       (%)
          (A)/(B)   (A)/(C)       (D)/(E)
Gross revenue    2,501    2,168    1,944    15    29    4,668    3,804    23 
Net revenue    2,058    1,727    1,491    19    38    3,785    2,918    30 
Cost of goods sold    (1,790)   (1,397)   (1,263)   28    42    (3,187)   (2,436)   31 
Gross profit    267    330    228    (19)   17    597    482    24 
Selling expenses    (10)   (12)   (6)   (18)   57    (21)   (18)   18 
General and Administrative expenses    (27)   (26)   (16)     71    (54)   (32)   66 
Depreciation and amortization    (3)   (3)   (3)       (6)   (6)   (0)
Other operating income (expenses)     (1)       (11)     11    (95)
Operating profit before financial result    229    288    204    (21)   12    517    437    18 
Net financial result    (2)     (14)     (86)     (16)  
Operating profit (loss)   227    293    190    (22)   19    520    421    23 
Other non-operating revenue (expenses)   (4)   (3)     31      (6)   (4)   47 
Profit (loss) before income tax and social contribution    224    290    191    (23)   17    514    417    23 
Income tax / social contribution    (75)   (97)   (55)   (23)   35    (172)   (133)   30 
Profit Sharing    (5)           (5)    
Net profit (loss)   144    193    135    (26)     337    284    18 
   
                 
   
EBITDA    288    346    262    (17)   10    634    552    15 
EBITDA Margin    14.0%    20.0%    17.6%    -6,0 p.p.    -3,6 p.p.    16.8%    18.9%     -2,1 p.p.
-Depreciacion and Amortization    59    58    58        117    115   
     • Cost    56    55    54        111    109   
     • Expense                  (0)
   

40


EXHIBIT XVII
Copesul Balance Sheet
(R$ million)

ASSETS    06/30/2007    03/31/2007    Change (%)
  (A)   (B)   (A)/(B)
Current Assets    1,643    1,327    24 
   • Cash and Cash Equivalents    689    400    72 
   • Accounts Receivable    200    256    (22)
   • Inventories    566    541    4 
   • Recoverable Taxes    161    106    51 
   • Advances to Suppliers    9    11    (20)
   • Others    19    12    59 
Long-Term Assets    164    157    4 
   • Compulsory Deposits and Escrow accounts    10    2    372 
   • Deferred income taxes and social contribution    17    16    10 
   • Recoverable Taxes    131    131    - 
   • Others    6    8    (29)
Fixed Assets    988    1,011    (2)
   • Investments    2    7    (75)
   • Plant, property and equipment    977    994    (2)
   • Deferred    9    10    (4)
   
Total Assets    2,795    2,495    12 
   
 
LIABILITIES AND SHAREHOLDERS' EQUITY    06/30/2007    03/31/2007    Change (%)
  (A)   (B)   (A)/(B)
Current    870    695    25 
   . Suppliers    488    275    78 
   . Short-term financing    72    172    (58)
   . Salaries and social charges    34    19    82 
   . Dividends/Interest on Equity    4    5    (7)
   . Income Tax Payable    184    105    76 
   . Taxes Payable    69    56    24 
   . Advances from Clients    8    0    - 
   . Others    10    65    (85)
Long-Term Liabilities    291    307    (5)
   . Long-term financing    205    232    (11)
   . Taxes Payable    45    38    20 
   . Others    40    37    8 
Shareholders' Equity    1,635    1,493    9 
   . Capital    910    910    - 
   . Revaluation Reserves    61    68    (11)
   . Capital Reserves    238    238    - 
   . Profit reserve    79    79    - 
   . Retained Earnings (Losses)   347    198    75 
   
Total Liabilities and Shareholders' Equity    2,795    2,495    12 
   

41


EXHIBIT XVIII
Copesul Cash Flow

(R$ million)

Cash Flow    2Q07    1Q07    2Q06    1H07    1H06 
Net Income for the Period    133    193    135    326    284 
Expenses (Revenues) not affecting Cash    24    47    71    71    96 
 Depreciation and Amortization    58    58    58    116    115 
 Interest, Monetary and Exchange Restatement, Net    (38)   (10)   10    (48)   (24)
 Others      (1)      
Adjusted Profit (loss) before cash financial effects    158    240    206    397    380 
Cash impact from Ipiranga Acquisition    0    0    (0)   0    80 
Asset and Liabilities Variation, Current and Long Term    370    (99)   54    271    71 
Asset Reductions (Additions)   62    (50)   (109)   12    (154)
           
 Marketable Securities      (4)   (11)   (4)   (29)
 Account Payable    125    (72)   (34)   53    (14)
 Inventories    (13)   29    (37)   17   
 Other Account Receivables    (51)   (3)   (26)   (54)   (112)
Liabilities Additions (Reductions)   308    (49)   163    259    225 
           
 Suppliers    213    (79)   85    134    89 
 Fiscal Incentives        19      45 
 Others    95    28    59    123    92 
Cash resulting from operating activities    528    141    260    669    531 
Investment Activities    (42)   (21)   (22)   (63)   (37)
 Fixed Assets    (42)   (21)   (21)   (63)   (36)
 Deferred Assets    (0)   (0)   (1)   (0)   (1)
Financing Activities    (176)   (49)   (250)   (225)   (376)
 Inflows    165    321    332    485    573 
 Amortization and Paid Interest    (340)   (169)   (397)   (510)   (675)
 Dividend/Interest attributable to Shareholders    (0)   (200)   (185)   (200)   (274)
   
 Cash and Cash Equivalents Increase (Reduction)   310    71    (11)   381    118 
Cash and Cash Equivalents at the beginning of period    272    201    163    201    33 
Cash and Marketable Securities at the end of period    582    272    151    582    151 
   

42


EXHIBIT XIX
Copesul Production, Sales Volume and Net Revenue
(R$ million)

Total Production    2Q07
(A)
  1Q07
(B)
  2Q06
(C)
  Change    Change    1H07
(D)
  1H06
(E)
  Change 
Volume          (%)   (%)       (%)
(ton)         (A)/(B)   (A)/(C)       (D)/(E)
 
• Ethylene    302,918    296,310    288,432    2    5    599,229    578,539    4 
• Propylene    155,018    155,478    153,776    (0)   1    310,495    304,813    2 
• Benzene    77,344    82,964    66,039    (7)   17    160,307    142,501    12 
 
Total Sales Volume
(ton)
  2Q07
(A)
  1Q07
(B)
  2Q06
(C)
  Change    Change   1H07
(D)
  1H06
(E)
  Change 
        (%)   (%)       (%)
        (A)/(B)   (A)/(C)       (D)/(E)
 
• Ethylene    303,117    299,950    293,392    1    3    603,068    572,111    5 
• Propylene    155,672    155,274    153,307    0    2    310,946    304,381    2 
• Benzene    78,261    84,049    71,261    (7)   10    162,310    141,259    15 
 
Total Net Revenue
R$ million 
  2Q07
(A)
  1Q07
(B)
  2Q06
(C)
  Change   Change    1H07
(D)
  1H06
(E)
  Change
        (%)   (%)       (%)
        (A)/(B)   (A)/(C)       (D)/(E)
 
• Ethylene    688    666    652    3    6    1,354    1,280    6 
• Propylene    347    351    340    (1)   2    697    688    1 
• Benzene    180    183    121    (2)   48    362    226    60 
                                 
                                 

43

 


EXHIBIT XX
Ipiranga Petroquímica Income Statement
(R$ million)

    2Q07
(A)
  1Q07
(B)
  2Q06
(C)
  Change     Change   1H07
(D)
  1H06
(E)
  Change 
Income Statement          (%)   (%)       (%)
          (A)/(B)   (A)/(C)       (D)/(E)
Gross revenue    606    659    606    (8)   (0)   1,264    1,234   
Net revenue    472    503    456    (6)     975    926   
Cost of goods sold    (392)   (416)   (410)   (6)   (4)   (808)   (829)   (2)
Gross profit    80    87    46    (8)   73    167    97    72 
Selling expenses    (14)   (14)   (11)   (3)   28    (28)   (17)   65 
General and Administrative expenses    (19)   (17)   (17)   10      (35)   (31)   14 
Depreciation and amortization    (1)   (1)         (2)   (1)   203 
Other operating income (expenses)   14    (3)   (0)       11     
Investments in Associated Companies    47    58    51    (20)   (8)   104    111    (6)
     •Equity Result    47    58    51    (20)   (8)   104    111    (6)
Operating profit before financial result    106    109    69    (3)   54    216    159    36 
Net financial result      (3)   (24)         (6)  
Operating profit (loss)   111    107    45      146    218    153    42 
Other non-operating revenue (expenses)     (0)   (0)          
Profit (loss) before income tax and social contribution    115    107    45      156    222    153    45 
Income tax / social contribution    (18)   (13)     36      (31)    
Net profit (loss)   98    94    53      83    191    155    23 
   
                 
   
EBITDA    68    60    25    14    171    128    63    102 
EBITDA Margin    14.4%    11.9%    5.5%    +2,5 p.p.    +8,9 p.p.    13.1%    6.8%     + 6,3 p.p.
-Depreciacion and Amortization            22    16    15    10 
     • Cost            (0)   14    14   
     • Expense        (0)           203 
   

44


EXHIBIT XXI
Ipiranga Petroquímica Balance Sheet
(R$ million)

ASSETS    06/30/2007    03/31/2007    Change (%)
  (A)   (B)   (A)/(B)
Current Assets    668    609    10 
   • Cash and Cash Equivalents    35    24    44 
   • Account Receivable    327    308    6 
   • Inventories    195    176    11 
   • Recoverable Taxes    62    35    78 
   • Advances to Suppliers    11    4    178 
   • Others    37    62    (40)
Long-Term Assets    241    253    (5)
   • Related Parties    0    0    - 
   • Compulsory Deposits and Escrow accounts    6    5    7 
   • Deferred income taxes and social contribution    118    121    (2)
   • Recoverable Taxes    2    116    - 
   • Others    115    11    993 
Fixed Assets    1,080    1,044    3 
   • Investments    571    524    9 
   • Plant, property and equipment    501    511    (2)
   • Deferred    8    8    (6)
   
Total Assets    1,989    1,906    4 
   
 
LIABILITIES AND SHAREHOLDERS' EQUITY    06/30/2007    03/31/2007    Change (%)
  (A)   (B)   (A)/(B)
Current    767    760             1 
   • Suppliers    584    527    11 
   • Short-term financing    126    128    (1)
   • Salaries and social charges    13    6    118 
   • Dividends/Interest on Owners' Equity    0    51    - 
   • Income Tax Payable    6    9    (32)
   • Receivable Taxes    23    21    6 
   • Advances from Clients    7    0    - 
   • Others    8    19    (59)
Long-Term Liabilities    500    569    (12)
   • Long-term financing    436    512    (15)
   • Taxes Payable    52    47    12 
   • Others    12    10    14 
Shareholders' Equity    721    577    25 
   • Capital    303    303    0 
   • Adjustment for Future Capital Increase    47    0    - 
   • Profit reserve    185    185    (0)
   • Retained Earnings (Losses)   187    89    110 
   
Total Liabilities and Shareholders' Equity    1,989    1,906             4 
   

45


EXHIBIT XXII
Ipiranga Petroquímica Cash Flow
(R$ million)

                                                               Cash Flow    2Q07    1Q07    2Q06    1H07    1H06 
Net Income for the Period    98    94    53    192    155 
Expenses (Revenues) not affecting Cash    (47)   (62)   (46)   (109)   (126)
 Depreciation and Amortization          16    16 
 Equity Result    (47)   (58)   (51)   (104)   (111)
 Interest, Monetary and Exchange Restatement, Net    (26)   (15)     (42)   (20)
 Others    18      (11)   20    (12)
Adjusted Profit (loss) before cash financial effects    51    31    7    82    29 
Cash impact from Ipiranga Acquisition    -    -    -    -    44 
Asset and Liabilities Variation, Current and Long Term    (70)   60    110    (10)   126 
Asset Reductions (Additions)   (81)   56    55    (26)   19 
           
 Account Payable    (20)   18    15    (2)   (39)
 Inventories    (19)   (10)   (11)   (29)   (6)
 Dividends Received        55      55 
 Other Account Receivables    (42)   48    (3)    
Liabilities Additions (Reductions)   11    5    55    16    107 
           
 Suppliers    45    35    (85)   81    (4)
 Others    (34)   (31)   140    (65)   112 
Cash resulting from operating activities    (19)   92    117    73    199 
Investment Activities    (3)   (4)   (4)   (8)   (8)
 Fixed Assets    (3)   (4)   (3)   (7)   (8)
 Deferred Assets    (0)   (0)   (0)   (0)   (1)
Subsidiaries and Affiliated Companies, Net    0    (24)   145    (24)   132 
Financing Activities    33    (61)   (255)   (28)   (267)
 Inflows    126    109    86    236    166 
 Amortization and Paid Interest    (140)   (170)   (132)   (310)   (224)
 Dividend/Interest attributable to Shareholders        (59)     (59)
 Others    47      (150)   47    (150)
   
 Cash and Cash Equivalents Increase (Reduction)   11    3    3    14    56 
Cash and Cash Equivalents at the beginning of period    24    21    96    21    44 
Cash and Marketable Securities at the end of period    35    24    100    35    100 
   

46


EXHIBIT XXIII
Ipiranga Petroquímica Production, Sales Volume and Net Revenue
(R$ million)

Total Production    2Q07
(A)
  1Q07
(B)
  2Q06
(C)
  Change    Change    1H07
(D)
  1H06
(E)
  Change
Volume          (%)   (%)       (%)
(ton)         (A)/(B)   (A)/(C)       (D)/(E)
 
 • PE´s - Polyethylene    118,917    122,925    124,985    (3)   (5)   241,842    243,452    (1)
 • PP - Polypropylene    36,431    36,936    34,617    (1)   5    73,367    69,599    5 
 • Total (PE´s + PP)   155,348    159,861    159,602    (3)   (3)   315,209    313,051    1 
 
   Total Sales Volume
(ton)
  2Q07
(A)
  1Q07
(B)
  2Q06
(C)
  Change    Change   1H07
(D)
  1H06
(E)
  Change
        (%)   (%)       (%)
        (A)/(B)   (A)/(C)       (D)/(E)
 
Domestic Market                                 
 • PE´s - Polyethylene    64,096    69,717    70,203    (8)   (9)   133,812    143,686    (7)
 • PP - Polypropylene    25,929    29,844    31,862    (13)   (19)   55,773    63,829    (13)
 • Total (PE´s + PP)   90,025    99,561    102,065    (10)   (12)   189,585    207,515    (9)
 
Export Market                                 
 • PE´s - Polyethylene    46,654    49,981    50,708    (7)   (8)   96,635    92,056    5 
 • PP - Polypropylene    13,242    3,950    3,579    235    270    17,192    10,758    60 
 • Total (PE´s + PP)   59,896    53,931    54,287    11    10    113,827    102,814    11 
 
Total Net Revenue
R$ million 
  2Q07
(A)
  1Q07
(B)
  2Q06
(C)
  Change   Change   1H07
(D)
  1H06
(E)
  Change
        (%)   (%)       (%)
        (A)/(B)   (A)/(C)       (D)/(E)
 
Domestic Market                                 
 • PE´s - Polyethylene    220    240    213    (8)   3    460    444    3 
 • PP - Polypropylene    92    106    101    (13)   (9)   198    203    (3)
 • Total (PE´s + PP)   312    345    314    (10)   (1)   657    647    2 
 
Export Market                                 
 • PE´s - Polyethylene    126    146    133    (13)   (5)   272    253    8 
 • PP - Polypropylene    34    12      190    271    45    26    74 
 • Total (PE´s + PP)   160    158    142    2    13    318    279    14 
                                 
                                 

47


SIGNATURES

        Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date:August 08, 2007

  BRASKEM S.A.
 
 
  By:      /s/      Carlos José Fadigas de Souza Filho
 
    Name: Carlos José Fadigas de Souza Filho
    Title: Chief Financial Officer

 

FORWARD-LOOKING STATEMENTS

This press release may contain forward-looking statements. These statements are statements that are not historical facts, and are based on management's current view and estimates offuture economic circumstances, industry conditions, company performance and financial results. The words "anticipates", "believes", "estimates", "expects", "plans" and similar expressions, as they relate to the company, are intended to identify forward-looking statements. Statements regarding the declaration or payment of dividends, the implementation of principal operating and financing strategies and capital expenditure plans, the direction of future operations and the factors or trends affecting financial condition, liquidity or results of operations are examples of forward-looking statements. Such statements reflect the current views of management and are subject to a number of risks and uncertainties. There is no guarantee that the expected events, trends or results will a ctually occur. The statements are based on many assumptions and factors, including general economic and market conditions, industry conditions, and operating factors. Any changes in such assumptions or factors could cause actual results to differ materially from current expectations.